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An iminium ion cascade sequence was designed and its implementation attempted 
to form the pentacyclic core structure of the natural product condylocarpine.  Trapping of 
the transient Pictet-Spengler-type spiroindolenium ion with a latent nucleophile would 
form two of the five rings of condylocarpine in a regioselective manner. 
Progress towards the first fully stereocontrolled synthesis of a lysergic acid 
derivative has been described.  The route utilizes intermediates with the appropriate 
oxidation state for the target, and the two stereocenters are installed via asymmetric 
catalysis.  The d ring and second stereocenter were simultaneously formed via an 
unprecedented microwave heated asymmetric ring closing metathesis (ARCM). 
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Chapter 1:  Condylocarpine Alkaloids 
1.1 INTRODUCTION 
The condylocarpine group of alkaloids is represented by their unique pentacyclic, 
cage-like structures (1.1, Figure 1).  They vary from other similar pentacyclic indole 
alkaloid families such as strychnos (1.2) and aspidosperma (1.3) by the skeletal 
connectivities of the C, D, and E rings (Figure 1.1).  The first condylocarpine type 
compound, aspidospermatine, was isolated from the bark of Aspidosperma quebracho-
blanco in 1882 by Hesse during his search for the source of the activity of “quebracho”.1  
However, aspidospermatine, as well as all of the compounds within the condylocarpine 
family, shows no noteworthy biological activity.  Condylocarpine itself was not isolated 
until 1961, and its structure was proven both by spectroscopic means and synthesis from 
stemmadenine.2,3  The absolute stereochemistry of 1.1 was deduced via chemical relation 





The proposed biogenesis of condylocarpine, put forth by Heimberger and Scott in 
their discussion of the biosynthesis of strychnine, is delineated in Scheme 1.1.5,6  The 
condylocarpine family is derived from geissoschizine (1.5) via two separate skeletal 
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rearrangements.  Initially, the extended tetracycle reforms to give 
dehydropreakuammicine (1.6), which has the strychnos skeleton, and then in a separate 
step the eastern C, D, E tricycle opens to give stemmadenine (1.7).  Rotation of the 
piperidine ring and reformation of a bond between the B and D rings gives the 
condylocarpine skeleton.  A potential reason for the route to proceed through 
dehydropreakuammicine instead of directly to condylocarpine may be due to mild steric 
repulsion of the ethylidene side group.  A similar case is the isomerization of condyfoline 
(1.9) to tubifoline (1.10) (Scheme 1.2).  Simply heating condyfoline provides, among 
other isomers, tubifoline, but heating tubifoline yields no condyfoline.7  There are no 
published values, but simple molecular modeling (MM2 level) indicates that tubifoline is 





The favoritism of the tubifoline isomer over the condyfoline isomer has played a 
pivotal role in the syntheses of compounds in these families.  In the syntheses of 
tubifoline and skeletally similar compounds, the preference was beneficial, but for 
condyfoline and skeletally similar compounds the preference was detrimental.  How 
different research groups have approached this issue is interesting. 
Scheme 1.2 
 
1.3 SYNTHESIS OF CONDYLOCARPINE ALKALOIDS – CONDYFOLINE AND TUBIFOLINE 
1.3.1 Synthesis of Condyfoline and Tubifoline by Harley-Mason 
The first synthesis of a condylocarpine alkaloid was performed by Harley-Mason 
when he synthesized both condyfoline and tubifoline in 1968.9  When readily available 
1.11 was treated with acetic anhydride, the intermediate acyl ammonium ion underwent a 
nucleophilic ring opening to 1.13, and the addition of potassium cyanide to 
tetraalkylammonium 1.14 proceeded in a similar fashion to 1.15 (Scheme 1.3).10  
Presumably the acyl ammonium ion is opened selectively due to the greater partial 





Realizing the potential of the newly functionalized indole, 1.11 was opened with a 
functionalized anhydride and, after careful hydrolysis of the ester, all of the necessary 
carbons for several frameworks had been installed in 1.16 without any yield data given 
(Scheme 1.4).9  Oxidation of the alcohol gave ketone 1.17, that cyclized upon exposure to 
strong base to form the D ring of 1.18.  Exhaustive carbonyl reduction created the 
skeleton of stemmadinine (1.19).  Oxidation of the amine to an iminium and subsequent 
cyclization gave both condyfoline (1.9) and tubifoline (1.10).  Benefiting from both the 
simplicity and the flexibility of this method, Harley-Mason used the approach to make a 





1.3.2 Synthesis of Condyfoline and Tubifoline by Ban 
 Capitalizing on a novel photocyclization adapted from a Fries type rearrangement 
that converted 1.20 to 1.21 (Scheme 1.5), Ban subjected tryptamine derivative 1.22 to the 
same conditions (Scheme 1.6).11  In all cases, the initially formed products 1.23 were 
unstable, but the addition of a tethered nucleophile trapped the product, and through a 
subsequent rearrangement macrolactam 1.25, which is reminiscent of Harley-Mason’s 
intermediate 1.16, was formed.  Reduction of 1.26, amine functionalization to provide 
1.27, and regioselective oxidation intercepted the Harley-Mason intermediate 1.17.  Ban 
continued to make a variety of natural products, including condyfoline (1.9) and 













































































1.3.3 Formal Synthesis of Condyfoline and Tubifoline by Snieckus 
Snieckus approached the synthesis of the stemmadenine system differently 
(Scheme 1.7).  The piperidine D ring was incorporated via a Horner-Wadsworth-Emmons 
(HWE) process to give 1.30 prior to formation of the indole nucleus.12,13  The ethyl 
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substituent of 1.31 was appended to the D ring via regioselective alkylation of the 
dienolate.  The regioselective alkylation of amide dianions had been known, but this was 
the first example with an unsaturated substrate.14,15
When the HWE was performed on a piperidine with the ethyl group already in 
place there was a significant reduction in yield making the two step process more 
efficient even though it was longer.  Reduction of the double bond followed by Madelung 
cyclization gave indole 1.32.  Demethylation of the amine and exchange of the 
trichloromethylacetamide for a monochloroacetamide provided the macrocyclization 
precursor 1.33.  Photocyclization of 1.33 gave 1.34 that was reduced to provide the 






1.3.4 Asymmetric Synthesis of Condyfoline and Tubifoline by Bosch 
 An asymmetric synthesis of 1.9 and 1.10 heavily based upon the approach of 
Snieckus was performed two decades later by Bosch et al.  Enzymatic resolution of a 
racemic mixture of pyridyl ethanol 1.35 provided enriched alcohol in 96% enantiomeric 
excess (Scheme 1.8).16  After reduction of the benzylated pyridinium ion to the 
corresponding tetrahydropyridine, the protecting group was changed to benzoyl, and a 
Johnson-Claisen rearrangement set the lynchpin chiral center in 1.36.  Indole synthesis 
and functional handle substitution gave the Witkop cyclization precursor 1.37.  
Compound 1.37 only differed from precursor 1.34 of Snieckus by containing an olefin 
and optical enrichment.  Cyclization furnished 1.38, reduction of both the amide and 







1.3.5 Formal Synthesis of Condyfoline and Tubifoline, and Synthesis of 
Dehydrotubifoline by Takano 
Takano synthesized Harley-Mason-type intermediates through a different 
approach.  Alkylation of thioamide 1.39 with methylbromocrotonate gave sulfonium salt 
1.40, which underwent a remarkable cascade of reactions upon treatment with base 
(Scheme 1.9).17  Tautomerization of the sulfonium ion 1.40 to the thioamino ketene acetal 
was followed by Claisen rearrangement.  Isomerization of the resultant vinyl double bond 
brought it into conjugation with the ester, and stereoselectively generated 1.41 with the 
E-ethylidene required for the final product.  Bischler-Napieralski-type cyclization 
garnered tetracycle 1.42; the ester was reduced to the alcohol, and subsequent cyclization 
formed 1.43.  Cleavage via dissolving metal reduction generated 1.44 containing the 
stemmadinine skeleton.  Macrocycle 1.44 was a formal precursor to both condyfoline 
(1.9) and tubifoline (1.10), and it also contained the unsaturated side chain with the 
proper stereochemistry for the strychnos class of alkaloids.  Interestingly, Polonovski-
Potier cyclization only provided dehydrotubifoline (1.45); no isomeric 
dehydrocondyfoline was detected.  Dehydrostemmadinine 1.44 may cyclize preferentially 




1.3.6 Synthesis of Tubifoline by Bosch 
All of the approaches discussed thus far share the stemmadinine type skeleton as 
either the target or the penultimate compound.  In a somewhat different approach, Bosch 
developed routes to tetracyclic uleine (cf. 1.48, Scheme 1.10) type alkaloids and then 
used these scaffolds as common intermediates containing the A, B, C, and D rings of the 
strychnos alkaloids. 
Starting from 1.46, made in two steps from isonicotinate, an iminium ion was 
generated in situ with acid, and indole was added.  The ethyl substituent was added, 
generating 1.47 as a mixture of diastereomers that were cyclized in a Friedel-Crafts 
fashion giving the dasycarpidan type structure 1.48 as an inseparable mixture of C(4) 
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epimers (Scheme 1.10).18-20  Lithium aluminum hydride reduction of the ketone followed 
by epimer separation and deprotection provided 1.49.  Alkylation of amine 1.49 with 
bromoacetaldehyde diethylacetal provided a functional handle for the introduction of the 
next ring.  The ethyl acetal was exchanged for a thiomethyl acetal generating 1.50, and 
upon exposure to dimethyl(methylthio)sulfonium fluoroborate (DMTSF) cyclized to form 
the E ring of 1.51.  Reduction of the thiomethyl group of 1.51 with Raney nickel 
concomitantly reduced the indolenine providing tubofolidine (not shown); however, 
acylation of the indolenine moiety of 1.51 proceeded with tautomerization of the double 
bond, and was followed by desulfurization to give 1.52.  Deprotection of the reduced 





1.4 SYNTHESIS OF CONDYLOCARPINE ALKALOIDS – TUBOTAIWINE AND LAGUNAMINE 
Among the interesting natural products of the condylocarpine family are 
tubotaiwine (1.53) and lagunamine (19-hydroxytubotaiwine, 1.54) (Figure 1.2).  More 
complex than condyfoline (1.10) and similar in complexity to condylocarpine (1.1), both 
of these alkaloids have an α,β-unsaturated ester appended adjacent to the indoline.  
Instead of the ethylidene moiety present in condylocarpine (1.1), they contain an ethyl 




1.4.1 Synthesis of Tubotaiwine by Harley-Mason 
Utilizing the dicarbonyl compound 1.18 from his synthesis of condyfoline and 
tubifoline, Harley-Mason added functionality to the α-aryl ketone instead of removing it, 
and expanded the series of alkaloids he could make from a single intermediate.21,22  Upon 
homologation of 1.18 to the methyl ester 1.55, subsequent treatment of the amide with 
phosphorous oxychloride made tubotaiwine (1.09) directly with no discussion of 
chemical efficiency (Scheme 1.11).  This unusual transformation presumably proceeded 
via a Vilsmeier-type salt, but the starting material and product are of differing oxidation 
states.  Giving no insight into the nature of the oxidation transfer Harley-Mason stated: 
… transannular cyclisation followed by disproportionation. As would be 
expected, the yield is low.22
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One of the most important features of this synthesis was the use of the amide to 
control the regioselectivity of the cyclization forming the C and E rings.  Although the 
yield was poor, the attempt to favor the tubotaiwine skeleton over the generally preferred 




1.4.2 Synthesis of Tubotaiwine by Bosch 
 Using a modification of his general approach to strychnos alkaloids Bosch made 
piperidinyl indole 1.56 (Scheme 1.12).23  While the indole synthesis of 1.57 and the 
installation of the cyano group providing 1.58 via Polonovski-Potier chemistry showed 
poor regio- and stereocontrol, almost all of the isomers are useful for different targets.  
Acidic ionization of the cyano amine 1.58 generated the desired iminium ion for 
cyclization of the c ring, and after extended reaction times the indole was conveniently 
deprotected yielding 1.59.  Attachment of the acetal, exchange for the thio-acetal analog 
1.60, and cyclization proceeded to 1.70 as in the tubifoline synthesis.  Protection of the 
indole and desulfurization gave 1.79, a regioisomer of tubotaiwine (1.53).  Subsequent 
rearrangement, rather than deprotection, provided tubotaiwine (1.53) by utilizing the 





1.4.3 Synthesis of Tubotaiwine by Kuehne 
 Indoloazepines have been extensively studied and utilized by Kuehne as central 
precursors to many families of indole alkaloids.24-54  Pictet-Spengler condensation of 
tryptamine (1.80) with methyl chloropyruvate  and treatment of the product (1.81) with 
pyridine provided the ring expanded azepine 1.83 via the aziridylcarboline 1.82 (Scheme 
1.13).32  This intermediate has been used by Kuehne to make members of the iboga, 
aspidosperma, and strychnos families as well as the condylocarpine alkaloids.  After 
reduction, condensation of 1.84 with acetaldehyde, ring opening, and Diels-Alder 
cyclization built tetracycle 1.87.  Treatment of 1.87 with acidic borohydride gave the 
indole 1.88.31  Protecting group manipulation, oxidation of the ester back to the α,β-
unsaturated ester 1.89, and deprotection provided the free amine.41  Addition of butanal 
initiated a cascade wherein the aldehyde condensed with the amine, which then 
 14





 Note that the initial seven steps were devoted to installing five carbons and 
making a Harley-Mason type intermediate 1.88 modified with an ester, and then 
immediately followed by three steps, 1.88 → 1.89, to reinstall a double bond that had 
been removed earlier.  To be fair, the relative simplicity of this inelegant synthesis does 
not show the strengths of Kuehne’s general approach based on indole azepines. 
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1.4.4 Synthesis of the (-)-Tubotaiwine Skeleton by Vercauteren 
 Vercauteren developed an intriguing Pictet-Spengler analogue using activated 
alkynes in place of aldehydes (cf. 1.91 → 1.92, Scheme 1.14) and then applied his 
method to the syntheses of indole alkaloids.55  The amino nitrogen of tryptamine 
derivative 1.91 added in a 1,4-manner to dimethyl acetylenedicarboxylate (DMAD), and 
addition of acid tautomerized the newly formed enamine into a reactive iminium ion that 
cyclized to give 1.92.  Combining this methodology with a rearrangement through 
intermediate 1.93, similar to Kuehne’s 1.81, and a chiral auxiliary very rapidly provided 
all of the carbons atoms for tubotaiwine (1.53) and set four contiguous stereocenters in 
1.94 (Scheme 1.14).56  The absolute configuration of 1.94 is opposite the configuration of 
the natural product, but Vercauteren claimed the rationale for the synthesis of the 
antipodal compound was based on the disparity of cost between the starting materials for 
either enantiomer of the chiral auxiliary.  Hydrogenolysis of the auxiliary and base-
induced cyclization gave the lactam 1.95 to which methyllithium was added forming 
ketone 1.96.  Oxidation of the 1.96 with selenium dioxide directly provided the lactam 




1.4.5 Synthesis of the Lagunamine by Vercauteren 
 In addition to tubotaiwine, Vercauteren utilized his surrogate Pictet-Spengler to 
synthesize other compounds in the family of condylocarpine alkaloids.  The synthesis of 
lagunamine (19-hydroxytubotaiwine, 1.54) not only showcased the method but also led to 
the elucidation of the stereochemistry of the natural product.  By performing the initial 
rearrangement with an aldehyde that contained a masked ketone, four contiguous 
stereocenter relative configurations were again set, and the product, 1.99, contained 
accessory functionality vs. 1.94 (Scheme 1.15).57  After revealing the ketone 1.100, it was 
reduced without regard to stereoselection to give 1.101 as a stereoisomeric pair, both of 
which were separated and independently carried forward.  After nitrogen deprotection 
gave 1.102, the three step ring formation/expansion was performed giving the skeleton of 
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lagunamine 1.105.  Upon exposure to Lawesson’s reagent, the pyruvamide 1.105 was 
transformed into the thio analog 1.106, and subsequently desulfurized with Raney nickel 
yielding 1.53.  Comparison of the spectral and chromatographic properties of the two 
alcohol epimers and of the natural products defined the previously unknown 























































































































1.5 SYNTHESIS OF CONDYLOCARPINE ALKALOIDS – CONDYLOCARPINE 
1.5.1 Synthesis of Condylocarpine by Harley-Mason 
 The first total synthesis of condylocarpine was performed, appropriately enough, 
by Harley-Mason.  In a concise paper he described, with minimal detail, the general 
synthesis of five natural products all arising from the single precursor 1.108 (Scheme 
1.16).58  Opening the tricycle 1.11 (Scheme 1.3) in this case with 2-bromo-3-
methoxybutanoic acid anhydride provided α,β-disubstituted amide 1.107 (Scheme 1.16).  
Treatment of 1.107 with sodium tert-pentoxide caused cyclization to form the D ring and 
eliminated methanol to form the ethylidene 1.108.  The ethylidene was formed as an 
easily separable pair of double bond isomers, and the isomer with unnatural geometry 
could be equilibrated to the natural isomer with sodium methoxide presumably via an 
addition/elimination sequence.  Wittig olefination gave 1.109, which upon hydrolysis had 
homologated the ketone to aldehyde 1.110.  Condensation of 1.110 with hydroxylamine 
to give 1.111 and subsequent dehydration produced a net oxidation of the aldehyde 1.110 
to nitrile 1.112.  Methanolysis of 1.112 revealed ester 1.113 as a pair of stereoisomers. 
Harley-Mason’s original intent was to completely reduce the amide of 1.113 to 
the amine providing the stemmadenine skeleton, but the N,O-acetal 1.114 was unusually 
stable.  More vigorous reaction conditions only served to reduce the ester moiety.  
Presumably the recalcitrance of the functional group is due to the anti-Bredt iminium ion 
that would necessarily form as the reduction intermediate.  Taking this stable N,O-acetal 
and using it to his advantage Harley-Mason, cyclized 1.114 under Lewis acidic 




 Harley-Mason’s synthesis of tubotaiwine and condylocarpine are interesting and 
stand out among the others because of the directed cyclization to form the C and E rings.  
While cyclizations of stemmadenine-like structures are not unusual, the majority of these 
proceed with little to no regiocontrol with regard to forming the carbon-carbon bond 
between the indoline and the piperidine ring.  In all other, non-directed, cases the 
strychnos skeleton is favored, and in examples with ethylidene side chains only the 
strychnos is seen.17,59
1.5.2 Synthesis of Condylocarpine by Kuehne 
 For Kuehne, accessing condylocarpine was relatively simple after his synthesis of 
tubotaiwine.41  Beginning from the same advanced intermediate 1.82, he deprotected and 
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then added the free amine to an ynoate in a 1,4-sense to make the vinylogous amide 1.115 
(Scheme 1.17).45  The amide 1.115 was isolated and in a separate step heated to effect the 
cyclization giving the C, D, E ring system 1.117.  In addition to the desired product 
1.117, a moderate amount of side product 1.116 was formed.  This side product was most 
likely formed from 1.117, perhaps due to the stability of the vinylogous amide versus the 
keto-amine.  Support for this hypothesis was found when 1.117 was heated, whereupon it 
cleanly opened to 1.116.  Treatment of side product 1.116 with acid reclosed the 
tetracycle in good yield.  Reduction of the ketone moiety provided a mixture of 
lagunamine and epi-lagunamine (1.53).  The lack of stereocontrol is unimportant because 
both isomers undergo elimination under the same conditions to provide a mixture (2:1) of 
condylocarpine and isocondylocarpine (1.1).  Either of the two isomers may be readily 
equilibrated to the same ratio of isomers upon treatment with acid or heat.  Subsequent to 
this study it was discovered that a natural sample of condylocarpine had isomerized upon 




 Kuehne proposed that the equilibrium took place via iminium ion formation and 
ring opening which reestablishes aromaticity (Scheme 1.18).  Elimination of a proton to 
satisfy the iminium ion led to dienamine 1.120 that underwent σ-bond rotation.  







 When viewing the condylocarpine alkaloids, the eye is drawn to the tricyclic 
eastern portion.  Immediately, as the quaternary spirocycle is noticed, methods of 
construction are contemplated.   The most intriguing aspects of synthetic design lay 
within the formation of these elements and how to achieve their control. 
While the approaches discussed have achieved the syntheses of several 
condylocarpine-type alkaloids, they often lacked control in the installation of the 
spirocyclic center of the indoline.  Almost all lacked power over the regiocontrol of the 
ethyl/ethylidene moiety.  In fact, all of the syntheses of both condyfoline and tubifoline 
took advantage of the substrates’ cyclization preferences; therefore, the product mixtures 
heavily favored tubifoline. 
 The syntheses of tubotaiwine were formulated in such a way that the spirocycle 
was formed in a controlled fashion.  Harley-Mason’s approach relied on an unexpected, 
fortuitous transformation, but proceeded in low yield.  Bosch built the spirocyclic center 
in several individual steps with only moderate control and yield.  Kuehne showed 
excellent control in his cyclization, but setting the stage for the transformation was long 
and convoluted. 
 Vercauteren’s syntheses of the tubotaiwine skeleton and lagunamine are 
interesting applications of novel chemistry and introduce asymmetry as well.  Several 
poor yields and the need for the late stage disposal of functionality lacks the elegance 
promised in the outset. 
 Building upon the methodological development of their respective processes, 
Harley-Mason’s and Kuehne’s syntheses of condylocarpine are similar in overall 
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approach to their syntheses of tubotaiwine.  Again they are effective, but also seemingly 
unnecessarily complex. 
 While condylocarpine type alkaloids have been synthesized, there is still ample 
space for further development.  The difficulty in synthesizing condylocarpine and similar 
alkaloids illustrates the continued need for methods to make multicyclic/spirocyclic 
alkaloids.  An efficient method to synthesize such spirocycles that was not at the mercy 
of substrate control would be very valuable.  Moreover it should be sufficiently general 
that the method could be applied to the synthesis of other multicycles/spirocycles. 
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Chapter 2: Studies Towards the Total Synthesis of Condylocarpine 
2.1 PRIOR ART FROM WITHIN THE MARTIN GROUP 
The Martin group has a long standing tradition in the total synthesis of alkaloid 
natural products, and as part of our ongoing efforts to develop general strategies for the 
efficient synthesis of members of the various subgroups of alkaloids, we have completed 
the total syntheses of a number of structurally diverse indole alkaloids.  In designing 
approaches to several of these syntheses, the key steps for skeletal construction were 
inspired by proposals for their biogenesis. 
Having recently completed a concise enantioselective total synthesis of (+)-
geissoschizine (1.5, Scheme 2.1), attention was turned towards its use as a precursor for 
other indole alkaloids.60,61  The ideal biomimetic precursor of a natural product would be 
its biogenic precursor, and based upon this premise the desired path of construction of 
condylocarpine (1.1) from geissoschizine (1.5) was outlined as shown in Scheme 2.1.  
Reductive cleavage of the bond connecting indole-C(2) to the piperidine ring followed by 
regioselective reoxidation would create a suitable precursor like 2.1 for a cascade of 
cyclizations creating the entire eastern portion of the structure of condylocarpine (1.1) in 
one sequence.  Deformylation of the pentacycle 2.4 and oxidation to the α,β-unsaturated 




 All of the attempts to cleave the C(2)-C(3) bond of geissoschizine (1.5) or similar 
analogs by Drs. Chen and Eary were unsuccessful, so this was revised. 62  The most 
interesting aspect of the synthesis was the proposed cyclization cascade starting with 2.1 
or 2.2.  To access the cascade, the racemic compounds 2.1 and 2.5 were synthesized and 
subjected to a variety of Polonovski-Potier and mercury acetate oxidation conditions 
(Scheme 2.2).  None of the reactions generated identifiable cascade products leaving 
instead starting materials, carbolines from simple iminium ion cyclizations, or complex 





The carboline side product 2.9 arose from formation of the iminium ion, but the 
pendant nucleophile of 2.1 was ineffective in trapping the indolenium ion intermediate 
(Scheme 2.3).  A possible mechanistic rational for the side product 2.9 was iminium ion 
formation from 2.1 followed by cyclization and subsequent iminium ion formation 
generating 2.7 or 2.8.  A second cyclization took place to provide product 2.9, wherein 
the enol, appended to the bottom of the molecules as drawn, attacked the intermediary 
iminium ion with the oxygen as opposed to the desired carbon atom.  Because both 2.7 
and 2.8 were potential precursors for 2.9, it was not possible to determine which was the 
actual precursor.  The desired spirocenter was not formed, and the dihydropyran was 




We hypothesized that if the method of formation of the initial iminium ion was 
more controllable and the latent nucleophile was more directed, i.e., monodentate, the 
cascade should be successful.  If the iminium ion formation was more controlled the issue 
of over oxidation of the reaction intermediates and/or products would be avoided (i.e. 2.7, 
2.8).  A nucleophile with a single mode of attack would suppress undesired side reactions 
such as the attack of the oxygen in the prior attempt (i.e. 2.8, 2.9).  An example of this 
type of reaction sequence was exhibited by Corey in his elegant synthesis of 
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aspidophytine (2.15) (Scheme 2.4).63  The use of the allylsilane in 2.11 as the latent 




 Modification and application of this concept to developing a synthetic approach to 
condylocarpine was straightforward.  Formation of the iminium ion 2.16 would initiate a 
Pictet-Spengler reaction, and the spirocycle would be trapped via allylation of 2.17, 
leading to 2.18 (Scheme 2.5).  The pendant vinyl group left in 2.18 would then be 
transformed into the requisite carbonyl group by oxidative cleavage followed by 
installation of the olefin providing condylocarpine (1.1) (Scheme 2.5).  Defining the 
chirality at C(4) of the piperidine ring in 2.16 would direct the formation of the rest of the 




 With this in mind, Dr. Eary redesigned the precursor.  He envisioned the iminium 
ion of 2.16 arising from a lactam and the pendant nucleophile as an allyl stannane (M = 
SnBu3).  In this way condylocarpine (1.1) could be made from 2.19 via 2.18 vide supra 
(Scheme 2.6)  The iminium ion precursor (2.16) to the cascade sequence would be a 
product of partial reduction and subsequent ionization of lactam 2.19.  The ethylidene 
would be available via aldol chemistry, and the stannane moiety would arise from 
displacement of an appropriate leaving group generated from protected alcohol 2.20.  
Formation of the lactam in 2.20 would result from the combination of 2.21 and 2.22, then 
reductive amination, and amidation.  Compound 2.22 would be the product of vinyl ether 
formation and Claisen rearrangement of allylic alcohol 2.23.  The alcohol 2.23 would be 
formed via deconjugative epoxide opening of 2.24, which would be made in 





 Dr. Eary began with inexpensive, readily available cis-1,4-butenediol (2.25), and 
following literature protocol, monoprotected 2.25 with a paramethoxybenzyl group, and 
epoxidized with peracid to give 2.26 (Scheme 2.7).64  While the initial foray into the total 
synthesis was racemic, it could easily be made asymmetric with the known 
enantioenriched version of 2.26 that has been made both with Sharpless methodology and 
from the chiral pool.65,66  Swern oxidation of the primary alcohol in 2.26 and subsequent 
olefination of the crude product mixture with triethylphosphonoacetate provided 2.24.  
Initially 2.24 was opened to provide 2.23 with magnesium metal in methanol,67 but 
higher yields and greater reproducibility were found using samarium diiodide.68  Vinyl 
etherification of 2.23 with ethyl vinyl ether and Claisen rearrangement provided 2.22 in 





2.2 CURRENT WORK 
2.2.1 First Generation Approach 
Immediately prior to the completion of his postdoctoral appointment within the 
Martin group, Dr. Eary synthesized several grams of 2.20 and performed initial 
experiments exploring the transformation of the protected alcohol to the allyl metal.  The 
allylic alcohol 2.20 was deprotected using dichlorodicyanoquinone (DDQ) in wet 
methylene chloride (Scheme 2.8).  Unfortunately, the conditions most commonly used to 
remove the paramethoxy benzyl ether protecting group are also conditions that efficiently 
oxidize the α-position of C(3) alkylated indoles.69  Thus, reaction produced a mixture of 
deprotected material 2.27 and deprotected oxidized material 2.29 in varying ratios.  The 
chromatographic and spectroscopic (1H-NMR) properties of the two compounds were so 
similar that Dr. Eary did not realize that there were two separate compounds in the 
product mixture.  Once this issue was discovered, it was also realized that selective 
deprotection using DDQ was not possible.  With the amounts of advanced material 2.20 





Of the available methods for removal of activated benzylic alcohols, the 
additional functionality of substrate 2.20 significantly limited the possibilities.  The 
presence of the indole nucleus rendered oxidizing techniques problematic, as was the 
case with DDQ.  Refluxing 2.20 in a 1% w/v solution of molecular iodine (I2) in 
methanol did effect the deprotection in moderate yield, but the reaction was accompanied 
by overoxidation of the primary alcohol to an aldehyde and a variety of polar side 
products that were not identified (Scheme 2.9).70  The isolated olefin made selective 
reduction difficult, and when 2.20 was exposed to mild catalytic hydrogenolysis 
conditions with palladium on carbon and 1,4-cyclohexadiene a product whose Rf did not 
match that of the desired compound was provided.  Heating 2.20 with chromium (II) 
chloride and lithium iodide in wet ethyl acetate appeared to react ‘spot to spot’ by TLC 
analysis, but the isolated yield of 2.27 was remarkably poor (11%).71  It is possible that 
the product adhered to the chromium salts and was not recovered; however, repetition of 
the procedure with more stringent extraction and recovery techniques did not improve the 
yield.  Strong acids, both Lewis and Brønsted-Lowry, removed the triisopropylsilyl 
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(TIPS) protecting group on the indole.  To circumvent this issue, a hard acid/soft 
nucleophile combination was used in the deprotection step.  Namely the mild Lewis acid 
cerium chloride hydrate and the nucleophile sodium iodide were used.72,73  The 
combination worked well providing the alcohol 2.27 in 63% yield.  When the protected 
alcohol 2.20 was refluxed in methanol with a catalytic amount of carbon tetrabromide, 74 





DDQ, CH2Cl2/H2O inseparable mixture of 2.27 & 2.29
I2 (cat.), MeOH, Δ 45%, 6% rsm, & 27% aldehyde
Pd/C (cat.), cyclohexene no product formation
CrCl2, LiI 11% 2.27
CeCl3•7H2O, NaI 63% 2.27
CBr4 (cat.), MeOH, Δ 70% 2.27 & 13% 2.20
CBr4 (cat.), MeOH
a 63% 2.27 & 12% 2.20
CBr4 (cat.), MeOH
b 49% 2.27 & 21% 2.20
a  sublimed CBr4 (0.5 eq.), sealed vial, 80-85 °C, 5.75 h
b  sublimed CBr4 (0.25 eq.), sealed vial, 95-100 °C, 1.5 h  
 
While deprotection of 2.20 with catalytic carbon tetrabromide in refluxing 
methanol was the most successful method, the reaction suffered from variable yields and 
the product mixture was difficult to purify.  A series of experiments determined that 
raising the temperature of the deprotection reaction of 2.20 increased the rate of 
production of 2.27 at least as much as it increased the rate of decomposition of 2.20 
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and/or 2.27.  The most practical method for the temperature insensitive reaction was to 
perform it at elevated temperatures for insufficient time to reach completion (Scheme 2.9 
final two entries).  In this way 2.27 was obtained in the highest reproducible yields based 
upon the recovered starting material, reaction times were reduced, and background 
reaction(s) that consumed the product were minimized.  Sublimation of the carbon 
tetrabromide immediately prior to use improved the yield slightly. 
The optimized deprotection process provided enough 2.27 for further 
investigations, but in the event that the deprotection would need to be revisited on a 
larger scale, a simple alternative was examined.  To avoid the difficulties associated with 
the transformation of 2.20 into 2.27, the PMP protecting group was removed at an earlier 
stage.  Thus precursor 2.30 underwent the Claisen rearrangement, and the crude product 
mixture was deprotected with DDQ to give 2.31, which was cyclized to provide 2.27 
directly (Scheme 2.10).  Although this initial foray was performed rapidly as a proof of 
concept with little care for ultimate yield, it still provided 44% over four steps (three 





 Preparation of the alcohol 2.27 for stannane displacement was straightforward.  
While mesylation of 2.27 worked poorly and was not reproducible, halogenation of 2.27 
under Appel type conditions to generate allyl chloride 2.32 worked exceptionally well 
(Scheme 2.11).75,76   During chlorination of 2.27, the addition of Hünig’s base to buffer 
the reaction was necessary.  Both of the allylic halides 2.32, X = Br, Cl, were stable and 
isolable as pure compounds facilitating the forthcoming displacement. 
Scheme 2.11 
 
 Initial difficulties in stannylation prompted a model study, which was performed 
on a simple allylic system (Scheme 2.12).  These studies showed that, in our hands, the 
quality of the tin hydride was of the utmost importance.  The tributyltin hydride (TBTH) 
was distilled prior to each use to ensure its purity and stored under nitrogen below 10 °C.  
Assays of the TBTH treated in this fashion always indicated greater than 97% purity.77  
Whether the allyl halide was chloride 2.33 or bromide 2.35 did not appear to influence 
yield, which was estimated from the 1H-NMR of the inseparable reaction mixture.  
Interestingly, the use of bromide 2.35 as a leaving group adversely affected the 






The allyl chloride 2.32 was then found to react smoothly with lithium 
tributylstannane to give 2.36 in good yield.  Addition of the enolate 2.36 to acetaldehyde 
installed the ethyl carbinol, providing 2.37 as a mixture of diastereomers (Scheme 2.12).  
Elimination of the alcohol from 2.37 by treatment with mild acid, base, or 
mesylation/elimination worked poorly or not at all.  Stereospecific syn-elimination of 
2.37 via the dicyclohexylcarbodiimide (DCC) imidate gave the ethylidene derivative 2.19 
as an easily separable mixture of E and Z isomers.79,80  The efficiency of the elimination 
was high, but the lack of stereocontrol in the aldol led to favoritism of the undesired Z-
double bond isomer of 2.19.  The ratio may have been inconsequential, however, because 
Kuehne had shown that the Z-ethylidene of isocondylocarpine (iso 1.1) was isomerizable 





 With 2.19 in hand attempts were initiated to invoke the cyclization sequence.  The 
desired pathway to access the cascade was reduction of the amide moiety in 2.19 to the 
hemiaminal, ionization of which would give the iminium ion 2.16 eliciting the Pictet-
Spengler reaction and the subsequent cascade (Scheme 2.13).  To attempt to control the 
reduction rate, diisobutylaluminum hydride (DIBAL) was slowly added to a solution of 
the substrate 2.19 at -78 °C.  The amount of reducing agent was carefully controlled to 
minimize the undesired reduction of the iminium ion 2.16 to the corresponding amine.  
Unexpectedly, there was no reaction at all, and addition of more DIBAL made no 
difference.  Employing stoichiometric or excess DIBAL in methylene chloride did not 
consume starting material 2.19.  Exposure of 2.19 to excess DIBAL in toluene at reduced, 
ambient, or elevated temperatures similarly appeared to do nothing.  The more active 
lithium aluminum hydride (LAH) provided minimal reaction with 2.19, providing 
unreacted starting material and over reduced piperidine 2.38.  Alane reduction of 2.19 
provided a product mixture that resembled the LAH reaction.  Apparently reduction of 
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2.19 to the hemiaminal was difficult, and the subsequent cyclization slower than the 




SM conditions temp. product(s)
E DIBAL-H (CH2Cl2) -78 °C to rt RSM
Z DIBAL-H (CH2Cl2) -78 °C to rt RSM
E DIBAL-H (toluene) -78 °C to rt RSM
Z DIBAL-H (toluene) -78 °C to rt RSM
Z DIBAL-H (toluene) rt to 70 °C RSM
Z LAH -78 °C to rt RSM, 2.38
Z AlH3 -78 °C to rt RSM, 2.38
RSM = recovered starting material  
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Reduction of similarly functionalized piperidones 2.39, to give 2.40, was rapid 
and near quantitative upon inspection (1H-NMR) of the crude product mixture (Scheme 
2.14).  Lactam 2.39 was a very simple model, so a small amount of the stannane 2.36 was 
subjected to the same conditions in hopes of forming either the desired pentacycle 
skeleton 2.41, or if the latent nucleophile was insufficiently reactive, the Pictet-Spengler 
reaction product 2.42 (Scheme 2.15).  The amide function in 2.36 was reduced slowly, 
but with significantly greater facility than that in 2.19.  Unfortunately, neither of the 
expected cyclization products 2.41 or 2.42 was seen; only reduced product 2.43 was 
isolated.  Apparently the interception of the iminium ion was significantly slower than 







 Another method to synthesize spirocyclic indolenines is the Bischler-Napieralski 
reaction.  Spiro intermediates from the Bischler-Napieralski reaction have been trapped 
with pendant latent nucleophiles independently by both Biswas and Jackson.81,82  Both 
research teams found that trifluoroacetic anhydride (TFAA) was effective in forming 
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imidate ions such as 2.45 and 2.48 from tryptamine-derived amides to initiate cyclization 
(Schemes 2.16 and 2.17).  As their traps, Biswas used veratrol 2.44 and Jackson used β-








 Bischler-Napieralski processes begin at the same oxidation level as 2.19, so 
instead of trying to partially reduce and intercept the transient intermediate 2.16, the 
formation of an imidate ion would be more facile.  Attempted mild formation of the 
imidate ion 2.51 (X = OMe) from 2.19 with Meerwein’s salt in the presence of 2,6-di-
tert-butylpyridine, caused no discernable reaction.  However, exposure of 2.19 to 
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trifluoroacetic anhydride resulted in compound 2.53.  The desired cyclization to 2.52 was 
again not seen, but the geometry of the ethylidene group in 2.53 had changed from Z to E.  
This could have been a secondary result of the formation of the long sought cation 2.51.  
If 2.51 were formed, tautomerization could lead to the energetically favored Z-isomer.  
Additionally, the stannane was lost, and to rule out adventitious acid as the culprit, the 
reaction was repeated in the presence of 2,6-di-tert-butylpyridine, but 2.53 was obtained 
again.  The data suggest the iminium ion may have been formed, but the cyclization was 
not taking place. 
Scheme 2.18 
  
R = conditions X = temp. product(s)
TIPS (CH3)3OBF4, di-t Bu-pyridine OCH3 rt RSM
TIPS TFAA OCOCF3 0 °C to rt 2.53
TIPS TFAA, di-t Bu-pyridine OCOCF3 0 °C to rt 2.53
H (CH3)3OBF4, di-t Bu-pyridine OCH3 rt RSM
RSM = recovered starting material  
 
The adverse result could have stemmed from deactivation of the indole as a 
nucleophile, or the inability of the nucleophilic indole C(3) and electrophilic iminium ion 
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to achieve sufficient proximity to react.  There are examples of silylated indoles 
undergoing the Pictet-Spengler reaction, and there is an isolated example from Nishida in 
which it was found that tert-butyldimethylsilyl protection was beneficial.83  However, 
this did not appear to be true of 2.19, and the bulk of the triisopropylsilyl group may have 
impeded the approach of the electrophile. 
Removal of the TIPS protecting group from 2.19 with fluoride ion proceeded 
smoothly to give 2.50, but upon exposure to Meerwein’s salt in the presence of 2,6-di-
tert-butylpyridine cyclization still did not take place.  The reluctance of 2.19 to undergo 
reaction prompted reexamination of it as the penultimate compound to the cascade 
initiator 2.16.  Concomitantly we aspired to make the approach to the putative cascade 
compound more expedient than the prior 14 step pathway. 
1.6.2 Second Generation Approach 
 The iminium ion cascade sequence stemming from 2.16 was still very attractive 
as a key transformation, but the approach to this intermediate needed to be modified.  The 
typical Pictet-Spengler reaction is initiated by the condensation of an amine and an 
aldehyde.  Using that disconnect made it apparent that the necessary iminium ion 2.54 
could be a product of the reaction of tryptamine (2.55) and 2.56 (Scheme 2.19).  Such a 
process would not only allow formation of two carbon-carbon bonds and two rings, it 
would also form the two carbon-nitrogen bonds of the piperidine ring all in one cascade.  
Although more was being demanded from the conversion 2.56 → 2.54 than 2.19 → 2.18, 
the novel route had the possibility of isolable useable intermediates (i.e., imine formation 
or amine displacement of the leaving group) if the reaction did not proceed all of the way 
to 2.54.  In the event of partial completion of the cascade sequence the intermediates 
would act as direct evidence of desired transformations as well as being useful for 
conversion to 2.54.  Like the first generation approach, the addition of the latent 
nucleophile was flexible, allowing for the introduction of different metals (M) should it 
prove necessary.  Overall, the transformation from 2.60 to 2.56 should be stepwise 




 The diene 2.58 was envisioned as the product of an addition/elimination 
sequence, where a vinyl cuprate would be added to an appropriately modified Baylis-
Hillman reaction adduct 2.59.  Unfortunately, the Baylis-Hillman reaction works 
notoriously poorly on α,β-unsaturated carbonyl compounds with substitution at the β-
position.84  To avoid this issue entirely, a modified approach was adopted wherein the 
allyl nucleophile was added to dihydropyrone 2.60 first to give 2.61.  Although the aldol 
reaction of 2.61 with acetaldehyde provided 2.62, the elimination to give 2.57 was 
unsuccessful, negating the benefit of the route as a quick and simple access to the key 
step precursor (Scheme 2.20).  Mesylation of 2.62 with methanesulfonyl chloride and 
triethylamine provided a mixture of sulfonylated alcohol diastereomers that were used 
 43
without purification.  Elimination of the mesylate mixture with 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) provided a complex mixture of compounds 
containing no 2.57.  Elimination of the mixture of mesylates with lithium 
diisopropylamide, via an E1cb mechanism, also produced a complex mixture of 
compounds, and no 2.57 was detected.  The DCC imidate elimination protocol that was 




1. MsCl, TEA, DMAP (cat.), CH2Cl2
2. DBU, PhH
1. MsCl, TEA, DMAP (cat.), CH2Cl2
2. LDA, THF, -78 °C
DCC, CuCl (cat.), PhMe, Δ
 
 Several alternate methods for the synthesis of Baylis-Hillman-type adduct 2.63 
were attempted (Scheme 2.21).  Intermediate 2.63 was more difficult to acquire than 





Recently, Jauch developed a novel selenation-elimination protocol to give a net 
Baylis-Hillman reaction of substrates not normally amenable to either standard or forcing 
conditions.84,85  For example enantioenriched γ-substituted butenolides such as 2.68 did 
not undergo Baylis-Hillman reaction under typical conditions, and when harsh 
conditions, i.e., stronger bases and/or higher temperatures, were used to promote the 
reactions, the enantiomeric excess of the epimerization prone butenolides was degraded.  
Jauch replaced the more common amine bases with a phenyl selenyl anion, apparently 
forming 2.70 from 2.69.  If the reaction was quenched with ammonium chloride at -78 °C 
compound 2.71 was isolated, supporting the hypothesis of 2.69 and 2.70 as intermediates.  
Elimination of phenyl selenol from 2.70 was promoted by either O-alkylating 2.70 with 
benzyl bromide, or by warming the reaction mixture containing 2.70, producing 2.72 in 




 Applying Jauch’s technology to dihydropyrone 2.60 proved immediately 
successful, and alcohol 2.64 was thus obtained in good yield (Scheme 2.23).  The product 
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mixture contained selenated compounds which gave additional amounts of 2.64 upon 
exposure to hydrogen peroxide.  Acetylation of 2.64 followed by vinyl cuprate addition 
provided diene 2.58 and a small amount of the diene corresponding to the direct 




 Olefin metathesis is finding more and more use as a standard olefination 
technique.86-89  The benefits include the ready availability of olefin containing starting 
materials and the ability of olefins to tolerate a wide variety of reaction conditions, 
allowing them to be carried through many steps without the need for protection.  In 
addition to the preeminent ring closing metathesis (RCM), cross metathesis (CM) is 
becoming progressively more commonplace.90,91
Using CM for incorporation of the allyl nucleophile greatly simplified 
introduction of the pendant nucleophile, and removed the multistep production of 
allylsilane cuprates previously needed (i.e., 2.60 → 2.61, Scheme 2.20).  The late stage 
CM also allowed different nucleophiles such as allyl stannane or allyl halide, for 
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conversion to an allyl metal, to be appended based on need.  The percent conversion of 
2.58 to 2.57 by CM with allyltrimethylsilane was somewhat variable, but the yield of 
2.57 was always good based on conversion (Scheme 2.23).  If allyltrimethylsilane were 
inadequately nucleophilic allyltributylstannane could be introduced in the same fashion 
using Schrock’s metathesis catalyst.92  It was necessary to open the lactone 2.57 in such a 
fashion as to be able to differentiate between the two oxygen bearing termini.  This goal 
was achieved via the formation of the so-called Weinreb’s amide 2.73.  Using Weinreb’s 
own aluminoamidation conditions proved inferior to the more reactive magnesioamide.93  
The magnesioamide must be made in situ via due to instability, so a common side 
reaction is addition of the Grignard reagent used to form the magnesioamide to the 
substrate and product.  Use of tert-butylmagnesium chloride instead of the more common 
isopropylmagnesium chloride reduced the amounts of undesired addition of the Grignard 
reagent to the starting 2.57 and 2.73.  Appel type halogenation of 2.73 and partial 
reduction of the Weinreb amide to the aldehyde gave the cascade precursor 2.56. 
 Exposure of aldehyde 2.56 to tryptamine (2.55) did not provide the cascade 
product 2.18 or any of the possible intervening intermediates, and the aldehyde was 
recovered in excellent yield (Scheme 2.23).  Increasing the temperature and/or time of 
reaction, and adding 4 Å molecular sieves did not give 2.18.  Activation of the aldehyde 
with trifluoroacetic acid or activation of the bromide with silver 
trifluoromethanesulfonate also did not give 2.18.  Performing the reaction in an NMR 
tube and monitoring progress by 1H-NMR indicated that the aldehyde 2.56 was 
untouched, and after extended periods (many days to several weeks) it would slowly 
degrade.  In many cases, the tryptamine degraded more rapidly than the aldehyde.  Using 
conditions that did consume 2.56 in a timely fashion, i.e., not multiple weeks, produced 
complex mixtures without key 1H-NMR resonances or low resolution mass spectra 
(LRMS) peaks characteristic of any desirable products or intermediates.  Spectra were 





X = solvent additives temp.
Br PhMe 4 Å sieves rt to 90 °C
Br EtOH - rt to 55 °C
Br CD3COD - 60 °C
Br toluene-d 8 4 Å sieves rt to 60 °C





 An example of a 1H-NMR reaction of 2.56 and 2.55 is shown in Figure 1.  The 
bottom spectrum is 2.56 in methanol-d4, the second from bottom is the same solution of 
2.56 with 2.55 added.  The rest of the spectra are of the mixture after heating at 35 °C for 
the specified times.  The aldehyde peak (ca 9.4 ppm) and the alkenyl proton β to the 
aldehyde (ca 6.8 ppm) never totally vanish, and are still visible at 50 elapsed days.  The 
inset is the low resolution mass spectrum (LRMS) of the reaction mixture taken at day 





Although aldehyde 2.56 should have readily reacted with tryptamine (2.55) it did 
not.  Anecdotal information about aldehyde to imine condensations, especially of α,β-
unsaturated aldehydes, indicates that the rate can vary widely from aldehyde to aldehyde 
and amine to amine without an obvious trend.  To probe the issue of severely moderated 
activity a simple cross comparison was performed.  A quick determination of the 
requisite reaction time of tryptamine (2.55) with crotonaldehyde and tiglic aldehyde did 
show that the α-substitution retarded the reaction, but both were still quite rapid and were 
essentially complete within 12 hours (Scheme 2.25).  Combination of 2.56 with 
benzylamine or hydrazine provided, again, only slow decomposition of the aldehyde 
(Scheme 2.26).  The series of 1H-NMR spectra of the reaction mixture containing 
benzylamine and 2.56 showed characteristic deshielding of the benzylic protons over 
time typical of falling pH, which would suggest that the bromide was being eliminated 
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from 2.56.  There was an excess of the amine to act as a base, so the hydrobromic acid 






 After the lack of success in activating either the aldehyde or bromide of 2.56, the 
nucleophilicity of tryptamine (2.55) was examined.  The use of aluminoamides as 
enhanced nucleophiles for esters is common, so they might also be useful for unreactive 
aldehydes.94,95  The known aluminoamide of tryptamine, 2.78,96 was combined with 2.56, 
but this reaction only provided decomposed material, albeit significantly faster than 





The known azide of tryptamine 2.80 was prepared and transformed into its aza-
Wittig reagent via a Staudinger reaction (Scheme 2.28).97  Addition of 2.56 to this 
mixture did not provide 2.79, but it did produce 2.81 in excellent yield.  This interesting 
side product may have arisen from 1,4-nucleophilic attack engendering 2.82, cyclization 






2.3 OUTLOOK AND CONCLUSIONS 
 The unusual stability of the key step precursors has made the total synthesis of 
condylocarpine (1.1) very challenging.  However, the greater the challenge the greater the 
reward.  A third generation approach designed upon the scaffold of the two unsuccessful 
routes is currently in the very preliminary stages of chemical exploration. 
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 While the total synthesis of condylocarpine (1.1) has yet to be achieved a number 
of interesting transformations have been utilized in the attempt.  The application of 
Jauch’s selenol-Baylis-Hillman reaction to a novel substrate exemplifies the substrate 
flexibility of the little-used transformation.  While the use of organoselenium compounds 
is generally avoided, the transformation of 2.60 to 2.64 was rapid, facile, and high 
yielding.  The addition of hydrogen peroxide (30%) to the work up procedure ensured 
that all of the selenium by-products were water soluble, and easily separated from the 
organic products.  The reaction can be an excellent alternative to some of the less reactive 
Baylis-Hillman reaction variants, in the transformation of sluggish activated alkenes. 
The vinyl cuprate addition/elimination sequence coupled with the cross 
metathesis proved to be an effective way to rapidly form substituted skip-dienes.  The 
CM reactions to install allyl trimethylsilane were performed in 2003, and since then the 
field has exploded with examples illustrating the diversity of CM as an olefination 
reaction surrogate. 
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Chapter 3: Methyl Lysergate 
3.1 INTRODUCTION 
The ergot family of alkaloids possesses the widest spectrum of biological activity 
found in any family of natural products.  Throughout its history, the fungi that produce 
the ergot alkaloids have been both boon and bane to those who come into contact with 
them.  Historically, people and livestock who inadvertently consumed grain tainted with 
ergot became ill or died, and recently ergotism (vomiting, diarrhea, hallucinations, and 
possible gangrene) has been proposed as the cause of perceived witchcraft leading to the 
Salem witch trials.98
Today, ergot alkaloids have found widespread clinical use, and more than 50 
formulations contain natural or semisynthetic ergot alkaloids.99 They are used in the 
treatment of an immense array of diverse conditions including uterine atonia, postpartum 
bleeding, migraine, orthostatic circulatory disturbances, senile cerebral insufficiency, 
hypertension, acromegaly (‘giantism’, a pituitary disorder), and Parkinsonism. New 
therapeutic applications are continually emerging such as those based on antibacterial and 
cytostatic effects, as well as immunomodulatory and hypolipemic activity.  The broad 
physiological effects of ergot alkaloids are based mostly on their interactions with 
neurotransmitter receptors on cells. The presence of pharmacophores resembling some 
important neurochemical mediators (e.g., noradrenaline (3.2), serotonin (3.3), dopamine 





3.2 BIOGENESIS OF THE LYSERGATES 
 The indole ring contained within the ergot framework implies tryptophan (3.7) as 
a precursor in its biosynthesis.  Through feeding experiments with 14C-labelled 
tryptophan, Mothes showed that this was in fact the case for ergometrine and ergopeptine 
(not shown).101  In similar fashion, several groups found that the incorporated isoprenyl 
unit was formed from mevalonate, parallel to terpene biosynthesis.101-107  The biogenic 
proposal involved mevalonic acid (3.5) being reduced to isoprene unit 3.6 and appended 
to tryptophan (3.7) to give 4-(γ,γ-dimethylallyl)tryptophan (DMAT, 3.8) (Scheme 3.1).  
An interesting facet of the biogenesis was realized with terminally 14C-labelled DMAT 
(3.8).  The DMAT (3.8) cyclized to form chanoclavine I (3.9) with the labeled carbon 
proximally disposed to the amine as drawn.  In the cyclization to agroclavine (3.10), the 
labeled carbon was ultimately positioned distally to the amine.  Terminal oxidation of 






3.3 SYNTHESIS OF LYSERGATES 
Due to their historical importance and medicinal utility, the ergot alkaloids have 
been extensively studied.  From the time when the first total synthesis of lysergic acid 
(3.12) was completed in 1954 by Woodward, it has remained a favorite target of synthetic 
chemists to showcase both novel methodologies and technical acumen.108  The intricacies 
of the biogenesis, i.e., the reorganization of the terminal methyl group location, and the 
migration of the double bond, add interest, but make a true biomimetic synthesis 
impractical.  The fact that indole containing tricycles such as Uhle’s ketone (3.13) are 
known to isomerize to the favored naphthol 3.14 represents an additional synthetic 






3.3.1 Synthesis of Lysergic Acid by Woodward 
 While the synthetic approach undertaken by Woodward and his research group 
was fraught with difficulties, they made some important decisions at the outset to 
minimize problems.108,109  To avoid the possibility of the indole C(2)-C(3) double bond 
migrating, it was omitted, a tactic adopted by other research groups in several later total 
syntheses of lysergates.  The reduced indole compound 3.16 was cyclized under Friedel-
Crafts conditions to give Kornfeld’s ketone (3.17), a reduced version of Uhle’s ketone 
(3.13) (Scheme 3.3).  The ketone 3.17 was α-brominated to give 3.18, and aminated to 
3.19 with functionalized amine 3.23.  At that stage, all of the skeletal carbons were in 
place save one, the ester carbon attached to C(8). 
Prior attempts to displace the bromide of 3.18 had failed, and an extensive study 
was performed to find a solution.  The solution that was found was laborious and, 
stepwise, quite lengthy.  Eventually it was discovered that if the amination of 3.18 was 
carried out in non-polar solvent it was successful, removing ten stages from the alternate 
route.  Hydrolysis of the ketal moiety in 3.19 followed by aldol cyclization and cleavage 
of the benzamide furnished 3.20.  The secondary amino group in 3.20 was acetylated, the 
ketone was reduced, and the product was made into the amine salt 3.21.  The alcohol in 
3.21 was homologated to the methyl ester 3.22 utilizing standard procedures.  Hydrolysis 
of the ester and oxidation of the indoline to the indole completed the first synthesis of 
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lysergic acid (3.12).  While the stereochemistry at C(5) and C(8) were not explicitly 
given, presumably it was trans as in the natural isomer.  Later when Ramage performed a 
formal synthesis of lysergic acid (vide infra), he intercepted the Woodward penultimate 
carboxylic acid (not shown).  Ramage used spectroscopic techniques unavailable to 
Woodward to show that Woodward’s carboxylic acid, and presumably 3.12, was a 




3.3.2 Synthesis of (+)-Lysergic Acid by Szántay 
 One of the more important contributions to the synthetic arena of the lysergates 
was the first enantioselective synthesis of lysergic acid by Szántay.111,112  The foremost 
goal was to develop an asymmetric and scaleable route to (+)-lysergic acid.  If the criteria 
were met, it would be an exceptionally valuable entry into the production of 
 57
 58
enantiomerically enriched lysergate analogs.  To achieve the latter goal, simple and 
effective chemistry needed to be used, so a route heavily based on that of Woodward was 
used. 
Beginning with a modification of the modern method of Goto, a derivative of 
Uhle’s ketone was synthesized from 3.24 (Scheme 3.4).113  Bromination of 3.24, 
followed by a series of protecting group manipulations, provided 3.25, which was an 
oxidized, deprotected version of Woodward’s intermediate 3.18.  Condensation of 3.25 
with 3.23 followed by enantiomeric resolution provided 3.26, which was an oxidized 
version of Woodward’s tetracycle 3.20.  The use of p-toluenesulfonylmethyl isocyanide 
(TOSMIC) allowed Szántay to homologate the carbonyl group of 3.26 via 3.27 in only 
three steps, as opposed to Woodward’s six, providing 3.28 as a mixture of diastereomers.  
According to Szántay, the hydrolysis of the methyl ester 3.28 concomitantly epimerized 
the mixture of diastereomers to (+)-lysergic acid (3.12).  It is worth noting that all other 
reported syntheses of lysergic acid, or advanced intermediates containing either an acid 
or ester function, have provided mixtures of diastereomers when treated with base, acid, 





3.3.3 Formal Synthesis of Lysergic Acid by Rebek 
 Another approach, starting from tryptophan (3.29), provided potential for an 
enantioselective synthesis.114  Racemic tryptophan (3.29), possibly used due to the higher 
cost of the unnatural isomer that has the requisite stereochemistry for (+)-lysergic acid, 
was first transformed into ketone 3.30 (Scheme 3.5).  Reaction of 3.30 with 3.36 in the 
presence of zinc led to 3.33.  At that point all of the skeletal elements and the appropriate 
overall oxidation state were in place; all that was required was reorganization of the 
lactone to the D ring.  Hydrobromination of 3.31 gave 3.32, which cyclized to 3.33 upon 
deprotection of the amine.  The lactone in 3.33 was opened giving 3.34.  Elimination of 
the tertiary hydroxyl group provided reduced methyl isolysergate (3.35), thereby 





3.3.4 Formal Synthesis of Lysergic Acid by Ninomiya 
In an approach similar to that of Rebek, Ninomiya capitalized upon a reductive 
photocyclization to form the D ring as the final ring.  A furan amide was appended to 
ketone 3.37, an isomer of Kornfeld’s ketone (3.17), to give cyclization precursor 3.38 
(Scheme 3.6).115  Exposure of 3.38 to light in the presence of sodium borohydride gave 
3.39 as one of three diastereomers.  All of the skeletal elements and the appropriate 
overall oxidation state were present.  Reduction of the amide 3.39 and osmylation of the 
dihydrofuran afforded 3.40.  Both diastereomers of diol 3.40 were cleaved removing the 
superfluous ring.  Oxidation of the formyl group in the presence of methanol afforded 
ester 3.45, which is an epimeric diastereomer of Rebek’s 3.34.  Elimination of the 






3.3.5 Formal Synthesis of Lysergic Acid by Ramage 
 It has long been known that (+)-lysergic acid and some of its derivatives could be 
racemized by treatment with hot, aqueous barium hydroxide.116  In a personal 
communication with Ramage, Woodward proposed that the racemization of (+)-lysergic 
acid (3.12) proceeded via the fragmentation of the D ring, possibly through 3.47, to the 
achiral tricycle 3.48 (Scheme 3.7).110  Addition of the amine in a 1,6-sense returned the 





 Based on the proposed mechanism of racemization of 3.12, Ramage wanted to 
make 3.48, or an appropriate analog, which would spontaneously generate lysergic acid 
(3.12).  Taking Kornfeld’s ketone 3.17 and transforming the carbonyl group into the α,β-
unsaturated moiety in aldehyde 3.49 gave Ramage a functional handle to attach the 
necessary elements of the D ring (Scheme 3.8).110  The Wittig reagent 3.54 provided the 
remaining skeletal carbons in 3.50 with exclusively the required double bond geometry 
for the key cyclization.  The tert-butyl ester was transformed into amine salt 3.51, the free 
base of which was ‘exceedingly reluctant’ to cyclize.  Methylation of the amine using the 
Eschwieler-Clark reaction gave, presumably via 3.52, a mixture of 3.46 and 3.53.  The 
secondary amine 3.52 cyclized sufficiently rapidly that it was not methylated a second 
time to give the dimethylamino analog.  The mixture of 3.46 diastereomers was carried 




3.3.6 Formal Synthesis of Lysergic acid by Kurihara 
 Following the same retrosynthetic approach as Ramage, Kurihara synthesized 
3.55, an analog of 3.48.117  Using aldehyde 3.49, all of the remaining elements of lysergic 
acid were appended by means of anion 3.58 (Scheme 3.9).  Deprotection of the amine 
and elimination of the alcohol from 3.55 provided a mixture of products 3.56 and 3.57 in 
similar ratio to 3.46 and 3.53 of Ramage, again presumably via the intermediacy of an 
α,β,γ,δ-unsaturated ester related to 3.52.  To complete the formal synthesis of lysergic 
acid (3.12), the ethyl ester of 3.56 was exchanged for a methyl ester, and the indoline 
amine was reprotected to intercept 3.46 a known compound in the formal synthesis of 




3.3.7 Formal Synthesis of Lysergic Acid by Ortar 
 Expanding on the approach of Ramage and Kurihara, Ortar made the enol-triflate 
3.59 from Kornfeld’s ketone (3.17) and performed a Heck coupling with 3.61 to give 





 The yield of the palladium coupling of 3.59 and 3.61 to give 3.60 was moderate, 
but the direct use of ketone 3.17 versus aldehyde 3.49 removed six steps.  That in 
addition to the increased efficiency with which the upper portion of the molecule was 
installed nets a significant improvement over the previous two routes. 
3.3.8 Synthesis of Lysergic Acid by Oppolzer 
Oppolzer developed an entirely different approach to lysergic acid.  Instead of 
forming the c ring and then appending the D ring sequentially, the C and D rings were 
formed simultaneously.  Beginning with indole carbinol 3.62, a masked diene, which 
would later be used in an inverse demand Diels-Alder reaction, was installed giving 3.63 
(Scheme 3.11).119  An oxime ether was introduced at C93) of the indole affording 3.64.  
Upon heating, retro [4+2] to deliver 3.65 that then cyclized by a Diels-Alder reaction to 
give tricycle 3.66.  Methylation of the amine of 3.66, reduction of the resulting 
methoxyammonium ion, and hydrolysis of the ester and concomitant migration of the 





In what is probably the most biomimetic synthesis of a member of the lysergates, 
Oppolzer pioneered a route that would be mimicked several times in the syntheses of 
ergot alkaloids outside the lysergate family.120
3.3.9 Formal Synthesis of Lysergic Acid by Julia 
In an alternate and unique approach, Julia reported an interesting formal synthesis 
of lysergic acid.  Although the synthetic plan was comparable with many of the other 
syntheses, the D ring was introduced prior to the C ring.  Methyl nicotinate (3.73) was 
condensed with 5-bromoisatin (3.68) to give 3.69 which contains almost all of the heavy 
atoms present for lysergic acid (Scheme 3.12).121  After reduction of the amide group in 
3.69 the resulting aniline was protected.  N-Methylation and reduction of the pyridine 
ring provided a mixture of isomers that were separated, giving 3.70.  Treatment of 3.70 
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with sodium amide cyclized the c ring, presumably via the intermediacy of the dienolate-
benzyne 3.71.  The product 3.72 was claimed to be the same as the Woodward 
penultimate indoline 3.22 (Scheme 3.3) if it were acetylated.  Because no yields were 




3.3.10 Synthesis of Lysergic Acid by Hendrickson 
 Hendrickson also developed a unique approach to lysergic acid, in which the c 
ring was formed last; however, the bond formed that closes the ring is on the opposite 
side of the C ring from the closure by Julia.  Coupling of indole-4-boronic acid (3.74) 
with chloropyridine dimethylester 3.77, regioselective reduction of one of the, now ethyl, 
esters to an alcohol, and oxidation of the alcohol to an aldehyde gave 3.75 (Scheme 
3.13).122  Base-promoted cyclization of 3.75, followed by reduction, provided tetracyclic 
methyl ester 3.76.  N-Methylation of the pyridine moiety, reduction of the ensuing 





3.3.11 Synthesis of Lysergic Acid Diethylamide by Vollhardt 
 Perhaps the most rapid synthesis of a lysergic acid derivative was performed by 
Vollhardt.  As an example of the utility of his [2+2+2] cyclotrimerization, 4-bromoindole 
(3.78) was transformed into 3.79 (Scheme 3.14).123  Exposure of 3.79 to alkyne 3.80 in 
the presence of catalyst, heat, and light gave a mixture of four compounds 3.81 - 3.84.  
The desired compound 3.81 was isolated in only 17% yield, but the expedient route 
somewhat offsets the poor yield.  After N-methylation and reduction of the pyridinium 







 From the time of the original synthesis of lysergic acid (3.12) by Woodward there 
have been a number of improvements in the approach to lysergates, and some exciting 
methods have been showcased.  Lysergic acid has been made enantioselectively by 
Szántay, and the formal synthesis by Ortar could potentially provide lysergic acid in as 
few as ten steps.  Vollhardt’s synthesis does not contribute greatly to the arena of 
lysergate total synthesis, but the exposition of his method is unparalleled in its stepwise 
efficiency.  While individuals have addressed specific problems, no one synthesis has 
addressed all of them.  In many of the syntheses, the indole C(2)-C(3) bond had to be 
reduced to preclude migration.  Szántay and Vollhardt found ways to work around the 
indole without reducing it, while Oppolzer and Hendrickson used the inherent 
nucleophilicity of indole in their syntheses. 
The C(9)-C(10) double bond has provided some difficulties to researchers either 
regarding its installation, or in the effect it has had on the C(8) stereocenter.  Woodward 
and Szántay installed the C(9)-C(10) double bond directly, but in such a fashion that the 
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C(8) chiral center was introduced later and without control.  Rebek and Ninomiya 
installed this double bond in the late stages of the synthesis by elimination, almost as an 
afterthought.  Ramage, Kurihara, and Ortar all installed the olefin during the key steps of 
their respective routes, albeit from an achiral precursor with no possibility for 
stereochemical control of the stereo centers.  Oppolzer, Julia, Hendrickson, and Vollhardt 
all had sp2 centers at C(8) of their penultimate compounds.  All of the syntheses 
contained some sort of equilibrating step late in the route that would give ratios of 
lysergates and isolysergates while the C(9)-C(10) double bond was migrated into place. 
To take full advantage of any synthetic natural product or natural product analog as a 
pharmaceutical, access to both enantiomers is necessary.  In some cases enantiomeric 
resolution is adequate, but enantioselective production of a compound is preferred once 
the desired configuration is known.  The synthesis of Szántay provided an 
enantioenriched product and was scaleable, but the chiral centers were resolved and 
equilibrated, not controlled during installation. 
The optimum route to the lysergates would address all of the prior issues, not just 
one or two of them.  The synthesis should be enantioselective, while maintaining 
expediency.  The installation of the stereo centers should be controlled, so that there is no 
C(8) epimeric mixture.  The oxidation states of the skeletal atoms should be modified as 
little as possible, i.e., the C(2)-C(3) double bond should be included for the entire time 
C(2) and C(3) are connected, not oxidized as a late stage transformation.  Similarly the 
C(9)-C(10) double bond should be installed as a double bond, not a masked equivalent of 
a double bond. 
Chapter 4: Studies Towards the Stereocontrolled Synthesis of (+)-
Methyl Lysergate 
4.1 PRIOR ART FROM WITHIN THE MARTIN GROUP 
The development of new and general strategies for the synthesis of biologically 
important natural and unnatural substances constitutes an area of considerable interest in 
organic chemistry.  In this context, we were attracted some years ago to the potential of 
using ring closing metathesis (RCM) reactions as key constructions for alkaloid 
synthesis.124-126  We have reported the application of such reactions to the syntheses of 
manzamine A (4.1), ircinal A (4.2), (+)-anatoxin-α (4.3), and (+)-8-epi-xanthatin (4.4), 
among others (Figure 1).127-132  As part of an ongoing program in developing the utility of 
RCM reactions, we were intrigued by the possibility of exploiting such a construction in 
formulating a novel synthetic approach to the tetracyclic ergot alkaloid methyl lysergate 







































 Prior to the current work, a synthesis of the C(8) unsubstituted analog 4.5 was 
examined.  The retrosynthetic analysis depended upon a late-stage RCM to provide 4.5 
(Scheme 4.1).133  The precursor of 4.5, diene 4.6, was seen as arising from deprotection 
and alkylation of amine 4.7.  The A, B, C tricycle 4.7 could arise from a derivative of a 




 Application of this route was straightforward.  Tosylation of 4-bromoindole (4.10) 
followed by coupling of the indole with dehydroalanine 4.13 provided the known 
dehydrotryptophan 4.8 (Scheme 4.2).134  Transformation of 4.8 by methylation and 
reduction gave the protected, racemic tryptophan 4.11.  Conversion of ester 4.11 to 
alkyne 4.12 was realized through a two step reduction/alkynylation protocol using the 
Ohira-Bestmann reagent.135,136  The cyclization to form the C ring was originally 
envisioned as arising from a radical process, but only traces of the desired 4.7 could be 
detected.  After different approaches were studied, the reductive Heck reaction was found 
to be the most successful.  Extensive optimization to minimize the formation of the 
undesired seven membered ring regioisomer made 4.7 available in reasonable yields.  
Deprotection of the amine in 4.7 followed by alkylation with 4-bromo-1-butene generated 
the key cyclization precursor 4.6.  Exposure of 4.6 to the first generation Grubbs catalyst 
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offered no reaction at all, but the D ring cyclization proceeded smoothly when the more 
reactive Schrock’s catalyst (4.15) was used.  Removal of the p-toluenesulfonyl group 




 The success of the RCM was very exciting, and it was envisioned that a new route 
to a variety of ergot alkaloids had been developed.  The RCM substrate 4.6 was thought 
of as potentially recalcitrant because there are few examples of exocyclic olefins as RCM 
substrates, and in particular, both 1,1-disubstituted and α-aryl olefins are poor substrates 
for Schrock’s catalyst.91  While the RCM did work, further elaboration of 4.5 did not.  
Attempts to install functionality at C(8) uniformly failed (e.g., Equation 1).  The creation 
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of analogs of 4.6 that contained an ester was difficult, and when successful would not 




4.2 CURRENT WORK 
 We envisaged that the ideal synthetic route to the lysergates would be 
enantiocontrolled, and have a minimum of oxidation adjustments.  There has yet to be an 
enantioselective synthesis of any of the lysergates that does not rely on a resolution, and, 
perhaps more importantly, both antipodes of both diastereomers should be available for 
pharmacological testing.  The chiral centers would be installed with chiral catalysts, to 
facilitate the construction of all stereoisomers using the same general synthetic sequence.  
The oxidation states of the skeletal atoms should be modified a minimum number of 
times for both the sake of asthetics and synthetic efficiency.  The indole core should be 
introduced as the fully aromatic system and preserve aromaticity for the entire synthesis.  
Similarly the C(9)-C(10) double bond should be in place as soon as C(9) and C(10) 
become connected and remain for the entire synthesis. 
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After completion of the synthesis of 4.5, the project lay dormant for a short while 
until RCM technology progressed to the point that it could be used for the synthesis of 
the lysergates.  The addition of a functional handle for later conversion to the ester 
moiety would circumvent the difficulties encountered in both appending a carbonyl to 
4.5, and performing a RCM on 4.16.  The elegant work of Schrock and Hoveyda in 
developing new asymmetric ring closing metathesis (ARCM) catalysts rekindled interest 
as a possible solution to these problems.137   
The desymmetrization of prochiral trienes with ARCM makes an intriguing 
approach to the D ring of the lysergates possible.  Whereas previously the C(8) position 
could not be functionalized before or after the metathesis, the cyclization of a triene to 
form the D ring would leave an olefin appended to C(8) as the requisite functional 
handle.  Additionally, an asymmetric catalyst would provide an entry to a controlled 
enantioselective synthesis, as opposed to a resolution based enantioselective synthesis 
such as that of Szántay. 
 Using the prior art from within the Martin group as a starting platform, the use of 
an ARCM to form the D ring fits seamlessly.  The carbonyl group of methyl lysergate 
(3.28) would arise from the olefin 4.18 by a series of oxidations (Scheme 4.4).  ARCM of 
4.19 would form the D ring and set the requisite stereochemistry at C(8).  Installation of 
the pentadienyl subunit on to R-4.7 should proceed analogously to the addition of the 
homoallyl side chain of 4.6 (Scheme 4.2).  The synthesis of compounds R-4.7, R-4.12, 
and R-4.11 would be similar to their racemic counterparts, with the absolute 




 The advent of chirally modified metathesis catalysts has extended the toolkit of 
the synthetic chemist.  The molybdenum based chiral catalysts 4.20 and 4.21 (Figure 4.3) 
among many others, have been used for creating chiral cyclic alkenes such as 4.23 from 
prochiral trienes like 4.22 (Equation 3), kinetic resolution of racemic dienes such as 4.24 
(Equation 4) and asymmetric ring opening metathesis-cross metathesis (AROM/CM) of 







 4-Bromoindole (4.10) is commercially available, but somewhat expensive 
($182.00 for 5 mL140), so it was synthesized in three simple steps from 2-methyl-3-nitro-
aniline (4.29, $88.30 for 100 g140).  N-Tosylation of 4.10 followed by coupling with 
dehydroalanine 4.13 gave 4.8 (Scheme 4.6).133,134  The use of stoichiometric palladium in 
the coupling step was undesirable, but studies performed by Yokoyama showed that poor 





The coupling was an opportunity to improve the existing synthesis, but it would 
need to be at least as rapid, and at least as efficient to be valuable.  Hegedus has reported 
some success in performing Heck couplings with the 4-bromo-3-iodoindole 4.31, 
complementing his palladium catalyzed indole synthesis (Scheme 4.6).141-144  While the 
dehydrotryptophan 4.32 that Hegedus made was similar in disposition to the desired 4.8, 
it was synthesized in three steps, versus only one to make 4.8 from 4.30, and was overall 
less efficient.  The salient feature of the Hegedus coupling was the selectivity between 
the two halides.  If a more advanced coupling partner were used to form the eastern 
portion of the amino acid with the same selectivity witnessed by Hegedus it would 




 Jackson has contributed greatly to synthesizing non-natural amino acids via 
Negishi couplings between zinc amino acid derivatives such as 4.34 and aryl halides, but 
he has never made tryptophan derivatives (cf. 4.11) (Scheme 4.7).145   If this chemistry 
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could be successfully applied to 4.31, the unnatural tryptophan 4.11 could be made 
directly without the intermediacy of the dehydro-analog 4.8.  While the yields from the 
coupling of both Jackson and Hegedus were moderate, that may have no bearing on the 




A few cursory experiments were performed to determine if a combination of the 
Hegedus and Jackson protocols was viable.  The organozinc rac-4.34 was formed 
following the Jackson protocol, and attempts to couple it with iodo-bromoindole 4.31 
were undertaken (Scheme 4.8).  There was no reaction, and 4.31 was recovered.  The 
organozinc reagent rac-4.34 was also coupled with 4-bromoindole 4.30 to give 4.38 
(yield not determined).  While the experiments were preliminary, the complete lack of 





In the previous route the highest yield in transforming 4.8 to 4.11 was realized 
when the amide nitrogen atom was methylated prior to reduction of the double bond 
(Scheme 4.9).  While the reduction was very efficient, it was also quite slow, taking ten 
days to go to completion.  If the steps were reversed, the yield suffered only slightly, and 




This situation has different implications for the enantioselective application.  The 
enantioselective reduction of enamides requires strong coordination of the 
amide/carbamate to optimize both yield and enantiomeric excess.146  If the 
amide/carbamate is tertiary, like 4.8, the coordination is not strong enough, and poor 
yields and enantiomeric excesses are observed.147  Yokoyama showed that not only did 
the enantioselective reduction of the N-methylated carbamate of 4.8 proceed with poor 
enantiomeric excess, but also the methylation after reduction of 4.8 completely racemized 





We had envisioned utilizing, in essence, the same route as Yokoyama, but wanted 
to have an enantiomeric excess higher than 55%.  To overcome the low 
enantioselectivity/racemization issue, the methylation was delayed until the chiral center 
was no longer labile.  The reduction of 4.8 was performed identically to a known 
example from Yokoyama, except the antipodal catalyst was used.134  Excellent yield and 
enantiomeric excess were realized when 4.8 was reduced with (1S,2S)-(+)-bis[(2-
methoxyphenyl)phenylphosphino]ethane (S,S-DIPAMP, 4.39) modified rhodium 
(Scheme 4.11).148  The absolute configuration of R-4.37 was confirmed by comparison of 
the optical rotation versus the literature value for the enantiomer; S-4.37: [α]D=-34 ° 

























 The ester function in R-4.37 was transformed into an alkyne by employing a 
diisobutylaluminum hydride (DIBAL) reduction followed by the Ohira-Bestmann 
protocol as for the synthesis of 4.12 (Scheme 4.2), but there was degradation of the 
enantiomeric excess of 4.40, from greater than 90% enantiomeric excess for 4.12 to less 
than 70% enantiomeric excess for 4.40.  Conditions were screened to optimize 
enantiomeric excess without sacrificing chemical yield.  After DIBAL reduction, the 
resultant aldehyde was exposed to different reagent/condition combinations, and the 
enantiomeric excess was measured.  Selected examples are presented in Scheme 4.12. 
Ohira’s reagent (4.14) provided the best ratio when the reduction and alkynylation 
were performed sequentially in the same reaction vessel without any isolation of the 
intermediate aldehyde (entry 3).  Upon completion of the DIBAL reduction, while still at 
-78 °C, the reaction was flooded with methanol, warmed to room temperature, and 
Ohira’s reagent and potassium carbonate were added in one portion.149  Lower 
temperatures tended to decrease the enantioselection and increase the reaction time 
(entries 1 and 2). 
Gilbert’s reagent (dimethyl(diazomethyl)phosphonate) provided good retention of 
enantiomeric excess, but the yields of 4.40 were consistently lower (in general, less than 
50%) than the Ohira’s reagent examples.  Practically speaking, Ohira’s reagent is both 
easier to make and use than Gilbert’s reagent, and was used in all subsequent 
alkynylations.135,150
In addition to Gilbert’s and Ohira’s reagents the anion of 
trimethysilyldiazomethane (TMSCH2N2) was examined.  The addition of the TMSCH2N2 
anion provided 4.40 with good enantiomeric excess, but the mass recovery of the crude 
product was quite poor (<50% possible yield), so it was not investigated further.  The 
Corey-Fuchs reaction was not attempted due to potential selectivity issues between the 





entry reagent solvent base temperature ee a
1 Ohira's MeOH K2CO3 -10 °C 70%
2 Ohira's MeOH K2CO3 0 °C to rt 72%
3b Ohira's MeOH K2CO3 rt 80%
4 Ohira's iPrOH K2CO3 0 °C to rt 50%
5 Ohira's iPrOH Cs2CO3 0 °C to rt 52%
6 Ohira's MeOH NaOMe -78 °C to rt 71%
7 Ohira's THF KOtBu -78 °C to rt 81%
8 Gilbert's THF KOtBu -78 °C to rt 87%
9 Gilbert's THF NaHMDS -78 °C to rt 84%
10 Gilbert's THF BuLi -78 °C to rt 83%
11 Gilbert's THF NaH -78 °C to rt 85%
12 TMSCH2N2 THF LDA -78 °C to rt 82%
a  Determined by chiral HPLC.
b  Reduction and alkynylation performed in one pot.  
 
 Performing the reductive Heck reaction on 4.40 provided the desired 4.41 along 
with some of the undesired, although not unexpected, regioisomer 4.42 (Scheme 4.13).  
The formation of the seven membered ring had been an issue in the similar conversion of 
4.12 to 4.7 in the synthesis of the lysergate skeleton (Scheme 4.2).133  Inexplicably, when 
the reaction was scaled up not only did the ratio of 4.41 to 4.42 degrade, but ketone 4.43 
was formed as the major product.  A possible mechanism for the formation of the ketone 
would involve one of two reasonable mechanistic hypotheses.  The interception of an 
alkenyl palladium species 4.44 via attack of the tert-butoxycarbonyl group oxygen on an 
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η1 palladium center, path A, followed by reductive elimination would provide 4.45 which 
would hydrolyze to 4.43.  Alternatively attack of the tert-butoxycarbonyl group oxygen 
on a carbon activated as an η2 palladium complex, followed by β-hydride elimination 
would provide 4.45. 
Scheme 4.13 
 
scale (4.40) 4.41 4.42 4.43
0.050 g 29% 9% -
0.350 g 15% 8% 22%
 
 The small amounts of 4.41 thus generated were carried forward.  The requisite N-
methyl group could be installed via reduction of the tert-butoxycarbonyl protecting group 
to improve the stepwise efficiency of the synthetic route.  In the event, reduction of 4.41 
with lithium aluminum hydride did not convert the tert-butoxycarbonyl group into the 
needed methylamino group (Scheme 4.14).  Methylation of 4.41 followed by 





 Simultaneous with exploring the cyclization/methylation approach, the alternate 
sequence of methylation/cyclization was being investigated.  N-Methylation of carbamate 
4.40 proceeded in good yield, but was difficult to reproduce (Scheme 4.15).  The yields 
of R-4.12 varied between near quantitative to less than 40%, with varying amounts of 
indole-deprotected starting material.  Eventually it was discovered that the reaction was 
temperature sensitive and required warming over a relatively short period of time.  If it 
was kept cold for too long or warmed too rapidly, the reaction did not go to completion.  
Fortunately, the rate of warming had some flexibility, and warming from -78 °C to room 
temperature over the course of 20 to 45 min was adequate.  If there was remnant starting 
material, the reaction mixture could be re-submitted to the reaction conditions.  Because 
the base sensitive ester functional group was no longer present, the issues Yokoyama 






agent warming rate R -4.12 4.40
MeI slow (overnight) 39% 26%
MeI normal (hours) 76% 18%
MeI, xs normal (hours) 84% 10%
Me2SO4 normal (hours) 93% 0%
Me2SO4 normal (hours) 68% 12%
Me2SO4 fast (< 1 hour) 93% trace  
 
 With the enantioenriched R-4.12 in hand for the reductive Heck reaction to 
provide 4.7, conditions were screened to attempt to improve on the prior 42% yield 
(Scheme 4.16).133  However, the prior work had explored a large array of reaction 
systems, and after several failed attempts it seemed as though there would be no 
improvement in yield of tricycle 4.7.  Eventually, it was discovered that the use of 
1,2,2,6,6-pentamethylpiperidine improved the yield of R-4.7 (not shown) in a 
reproducible fashion.  In providing 4.7, racemic or enriched, the product mixture was a 
complex mixture of inseparable compounds including 4.7.  Much of the prior work 
optimizing this transformation was aimed at reducing the side products to improve the 
recovery of pure 4.7.  Fortuitously it was found that the next reaction in the sequence, 
deprotection of the amine in 4.7 to give 4.46, was unaffected by impurities, and provided 
a much more easily separated mixture of products.  With these two improvements the 





 The installation of the pentadienyl subunit onto 4.46 in anticipation of the ARCM 
was an issue of some concern.  While branched pentadienyl-containing molecules were 
not unknown, they were far from common and there were few general methods for 
putting them in place.151  Model studies were performed to determine what method or 
methods would best be applied to the precious 4.46.  Attempted alkylation of 4.47 with 
4.49152 using cesium carbonate in refluxing THF, as in the alkylation of the deprotected 






 Coupling of the amine 4.47 with acid 4.52152 worked, but the reaction gave the 
conjugated products 4.51, not the desired 4.50 (Scheme 4.18).  It was likely possible to 
deconjugate 4.51 to provide 4.50, but this procedure would have made for inefficient 




 One of the more general methods of installing pentadienes was by use of a 
pentadienyl metal reagent 4.53 (Scheme 4.19).  For example the addition of a 
coordinating pentadienyl metal to an aldehyde 4.54 undergoes an allylation type reaction 
via a Zimmerman-Traxler transition state 4.55.151,153,154  The alternative pentadienylation, 
giving the linear product, has to go through an unfavored eight membered transition state 
4.56a or allylate via the unfavored branched 4.56b, and is generally not seen.  However, 
the organometal 4.53 cannot add to an iminium ion 4.58 via the same coordinated 
transition state.  There are no coordinating sites on the nitrogen atom, so it must 
pentadienylate through an open transition state like 4.59 or 4.60.  Unfortunately, this 
generally leads to mixtures of both 4.61 and 4.62 with no real recourse to control the 
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isomer ratio.  While it is difficult to make a prediction of the outcome of the 
pentadienylation of an iminium ion, Miginiac has contributed an abundance of empirical 




Several electrophile surrogates were synthesized and tested to determine what 
protocol would provide the best yield of branched pentadiene with the greatest 
reproducibility.  An abbreviated version of these experiments is presented in Scheme 
4.20.  The salient points learned from the study were:  organozinc reagents and 
tetrahydrofuran as solvent gave the best yields and ratios of 4.48 to 4.67; the N,S- and 
N,O-acetals were both more effective as electrophile precursors than the cyanoamine, but 
the N,O-acetal was easier to synthesize and handle.  Bis-pentadienylzinc provided higher 
yields and greater reproducibility than pentadienylzinc bromide.  A possible explanation 
for the greater efficacy is that the reduced Lewis acidity of the diorganozinc may ionize 
the N,O-acetal to a lesser extent in the transition state, allowing more opportunity for 








 Compound 4.63 (Nu = OMe) could be purified via distillation to remove excess 
solvent while maintaining the integrity of the N,O-acetal.  However, the N,O-acetal 4.68 
derived from 4.46 could not be distilled, so the solvent was removed rapidly in vacuo, 
before being replaced with tetrahydrofuran (Scheme 4.21).  Bispentadienylzinc addition 
to 4.68 provided 4.27 in similar yields to the best examples from the addition of 
pentadienylzinc bromide to 4.68.  Additionally the use of bispentadienylzinc proved more 





 With 4.27 in hand, the RCM experiment was performed with the achiral 
Schrock’s catalyst 4.15.  In an unexpected result, exposure of 4.27 to 4.15 produced no 
reaction at all, returning 4.27 quantitatively (Scheme 4.22).  The use of a large excess of 
catalyst, and heat offered no change.  Subjecting 4.27 to 4.15 in toluene and heating to 
100 °C also returned starting material.  Grubbs’ second generation metathesis catalyst 
4.70 was similarly unreactive with 4.27.  The addition of titanium isopropoxide to 4.27 
prior to exposure to 4.70 gave the same result.161  The Grubbs-Hoveyda second 
generation catalyst 4.71 consumed some 4.27, but there was no detectable 4.28 in the 
product mixture.  The racemic Schrock-Hoveyda catalyst 4.20 did not react with 4.27 in 





catalyst solvent temp. product
25% 4.15 PhH rt 4.27
50% 4.15 PhH Δ 4.27
50% 4.15 PhMe 100 °C 4.27
500% 4.15 PhH Δ 4.27
300% 4.15 PhMe 100 °C 4.27
20% 4.70 CH2Cl2 Δ 4.27
50% 4.70 CH2Cl2 Δ 4.27
50% 4.71 CH2Cl3 Δ 4.27a
20% 4.70, Ti(Oi -Pr)4 CH2Cl2 Δ 4.27
a
20% (±)-4.23 PhH Δ 4.27
a  Slight decomposition of 4.27  
 
 The surprising lack of reaction between 4.27 and 4.15 may have been due to 4.27 
coordinating with catalyst 4.15 in a non-productive fashion.  If that were the case the 
catalyst should be deactivated towards alternate substrates as well.  To explore this 
possibility 4.15 was incubated with 4.27 in benzene at reflux temperature for 15 minutes 
followed by the addition of 4.73, a known substrate for 4.15 (Scheme 4.23).162  The 
diallylamine 4.73 was completely consumed, and 4.27 did not react at all.  The 
implication of that reaction was that if 4.27 was coordinating 4.15 it must have been a 
reversible process.  It was interesting to note that the subtle difference between 4.27 and 
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4.6 (Scheme 4.2), i.e., a vinyl group, was sufficient to shut down the RCM of 4.27 with 




 The substrate 4.27 was completely recalcitrant, but did not deactivate the 
Schrock’s catalyst (4.15).  Diene 4.6 (Scheme 4.2), which only differed from 4.27 by the 
extra vinyl group had been a good substrate for RCM with catalyst 4.15.  Because of this 
it was proposed that the cause, at least in part, of the reticence of 4.27 to undergo RCM 
somehow hinged upon the additional vinyl group.  The catalyst 4.15 and the triene 4.27 
may have formed some sort of non-productive coordination complex such as those shown 
in Figure 4.2. 
 The pentadiene moiety has been used successfully for stereoselective RCM 
reactions, so it seems unlikely that a coordination complex such as 4.74 or 4.75 could be 
the unreactive culprit.138,163  The fruitful RCM of 4.6, which contained a homoallylamine, 
counters either 4.76 or 4.77 as the inhospitable complex.  There was no way of gathering 
direct evidence to support or refute 4.78 or 4.79 as possibilities, but they were the only 
reasonable complexes unique to this system.  Both of the alkenes of the gem-divinyl 
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 Because 4.27 was already available, the initial amine modifications were 
performed on this substrate.  A generalization about the ruthenium based metathesis 
catalysts, such as the Grubbs type catalysts 4.70, is that they sometimes work poorly on 
substrates with Lewis basic sites such as amines.  A common method to alleviate this 
problem is to protonate the amine.88  Molybdenum based metathesis catalysts, such as the 
Schrock catalyst 4.15, are incompatible with protic acids, so if a Lewis basic site needs to 
be engaged it must be done another way. 
To remove the Lewis basic site, the amine was subjected to quaternization to 
completely occupy the lone pair.  Adding a large excess of benzyl bromide to 4.27 in 
dimethylformamide in the presence of tetrabutylammonium iodide led to no reaction 
(Scheme 4.24).  Methylation of 4.27 in neat iodomethane with silver oxide also failed.  
Methylation of 4.27 with methyl triflate in the presence of 2,6-di-tert-butylpyridine, 
however, did provide a small amount of product that may have been 4.80.  The product 
mixture decomposed during chromatography, the 1H-NMR was difficult to de-convolute, 
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and exposure of the mixture to Schrock’s catalyst 4.15 did not provide RCM product.  
The difficulty in formation and characterization of ammonium ion 4.80 made it a less 
than desirable intermediate, and other tactics for the functionalization of the amine lone 




reagent base solvent R =
BnBr, Bu4NI - DMF





 An alternate method of functionalizing the amine was to append a protecting 
group to the amine.  The concomitant N-methyl cleavage and carbamate protection of 
4.27 by treatment with a chloroformate was undertaken (Figure McKlusky).164  
Unfortunately the desired cleavage did not take place providing recovered 4.27 and 
degradation.  The route to the pentadiene was modified to retain the tert-butoxycarbonyl 
protecting group.  To accomplish this a different method of installing the pentadiene 
moiety was used.  With the carbamate protecting group on the nitrogen, any iminium ion 
formed would be an N-acyliminium ion.  N-Acyliminium ions follow the reactivity trends 
for pentadienylation of iminium ions and tend to give excellent regioselectivity for the 
linear isomer (cf. 4.69), not the branched isomer (cf. 4.27).  While N-acyliminium ions 
are poor electrophiles for pentadienylation to the branched product, they can be excellent 
electrophiles for allylation.  If the N-acyliminium ion was allylated with an allylating 
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agent containing a masked alkene then the desired nitrogen-protected pentadiene could be 
made in a slightly longer, but straightforward fashion. 
Scheme 4.25 
 
An ionizable group was necessary in the place of the previous N-methyl group.  
To this end compound 4.40 was alkylated with chloromethyl methyl ether, so that, in 
conjunction with the tert-butoxycarbonyl group, the N,O-acetal could be used as an N-
acyl iminium ion precursor (Scheme 4.26).  The N-alkyl group assisted in the reductive 
Heck cyclization of 4.82 to give 4.83 in that it had been found that tertiary carbamates are 
more successful than secondary carbamates (vide supra).  The cyclization of 4.82 to 4.83 
followed by allylation of the N-acyl iminium ion of 4.83 generated in situ with 4.88, gave 
4.84.165  Treatment of 4.84 with tetrabutylammonium fluoride revealed alcohol 4.85, 
which, upon elimination, gave triene 4.86, the N-Boc analog of 4.27.166,167  When tert-
butoxycarbonyl protected 4.86 was treated with 4.15 in benzene under reflux, 4.87 could 





 The complete lack of success of the key RCM of 4.27 and 4.87 prompted a 
reevaluation of the route.  While methods for realizing the key metathesis were being 
considered, the Martin research group made an important and serendipitous acquisition.  
A CEM Discover microwave reactor was procured.  It is well known that microwave 
heating can accelerate, and improve the efficiency of transition metal mediated 
processes.168  That fact notwithstanding, there is no record of molybdenum based 
metathesis catalysts ever having been used in conjunction with microwave heating. 
 In the event, a solution 4.27 and 50 mol % 4.15 in benzene was heated in the 
microwave reactor at full power (300 W) for 10 min, and 4.27 was completely consumed 
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(Scheme 4.27).  Gratifyingly, the long sought ABCD tetracycle 4.89 was isolated in a 
modest 25% yield along with a small amount of the separable epimer 4.28.  The chemical 
shifts of the protons were assigned with the aid of the COSY spectra of 4.28 and 4.89, 
and the relative configurations were subsequently assigned based upon the nOesy spectra.  
The configuration of the C(5)-H was known, so it was used to determine the relative 
configuration of the newly formed stereocenter by using nOe data to ‘walk’ around the D 
ring (Figure 4.5).  Although the goal had been to synthesize methyl lysergate with the β 
absolute stereochemistry at C(8), there is variety of natural products with α 
stereochemistry at C(8) so the RCM was still a valuable step.  When mixtures of methyl 
lysergate and methyl isolysergate were treated with base the mixture equilibrates favoring 
the so called normal stereochemistry.  The formation of the iso stereochemistry is 
disfavored, so the favoritism of 4.89 over 4.28 was in reality a quite an accomplishment.  
Reduced catalyst loads of 10 mol % or 30 mol % were insufficient for complete 
consumption of 4.27.  After some experimentation the use of catalyst 4.15 and 300 W of 
irradiation was optimized to 36% 4.89 and 8% 4.28.  After this exhilarating success, the 
next logical extension was to determine if the chiral catalyst 4.20 would be an 
improvement versus the achiral catalyst 4.15. 
The literature covering the chiral metathesis catalysts does not contain any 
pneumonic for determining which enantiomer should be used for a given substrate.137  
Regardless, no substrates of the complexity of 4.27 have ever been subjected to 
enantioselective metathesis reactions.  Inspection of published reactions (cf. 4.16 → 4.17) 
suggested that S-4.20 (Scheme 4.3) would provide 4.28 in preference to 4.88.138,169  This 
was not found to be the case, but S-4.20 catalyzed the ARCM of 4.27 with an improved 
47% yield of 4.89 and 18% yield of 4.28 versus the 36% yield of 4.88 and ca 8% yield of 
4.28 when the achiral 4.15 was used.  When 4.27 was exposed to R-4.20 under identical 
conditions as the S-4.20 catalyst reaction, ~55% of 4.27 was consumed but only trace 
amounts of 4.28 and 4.89 were isolated.  In addition to the reduced amounts of desired 
products there was a significant increase in the amount of a side product that was most 
likely the Δ8,9 double bond regioisomer of 4.28/4.89.  The Δ8,9 regiochemistry was 
determined by 1H-NMR and LRMS data, and by the fact that treatment of the 4.89 with 
catalyst 4.15 also provided the isomer.  Reduced loads of catalyst S-4.20 provided 4.89 in 
higher yield than reduced loads of 4.15 had, but likewise did not completely consume the 
starting material.  Reducing the microwave power transferred to the reaction vessel to 50 
watts and extending the reaction times to 30 minutes improved the yield of 4.89 to a 




catalyst power time 4.89 4.28
10% 4.15 300 W 10 min - -
30% 4.15 300 W 30 min trace -
50% 4.15 300 W 10 min 36% ~8%
50% S -4.23 300 W 10 min 47% 18%
50% R -4.23 300 W 10 min see text
30% S -4.23 300 W 10 min 39%a na







 After it was discovered that the microwave heating promoted the RCM from the 
amine substrate 4.27, carbamate 4.86 was subjected to the same conditions as for the 
initial RCM of 4.27.  Exposure of a benzene solution of 4.86 to microwave heating (300 
W) in the presence of 50 mol % of either 4.15 or 4.72 did not provide 4.87 (Scheme 
4.27).  It appeared that carbamate 4.86 was actually a worse substrate for the RCM than 




 Although the original synthetic goal had been to synthesize methyl lysergate 
(3.28), the predominance of the epimeric metathesis product 4.89 was not seen as a 
negative result.  A large number of lysergate natural products have the iso absolute 
configuration of 4.89 at C(8) and the material was moved forward to synthesize methyl-
isolysergate. 
With the long sought tetracycle 4.89 in hand, conditions to cleave the vinyl olefin 
to the ester were explored.  To selectively functionalize one of the two double bonds in 
4.89, our initial approach was through the cleavage of an appropriate diol.  
Dihydroxylations are a useful method of selectively functionalizing one olefin in the 
presence of another based on steric differences between the two, and one of the most 
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successful reagents for steric discrimination between olefins is the asymmetric 
dihydroxylation (AD) mix.170  Unfortunately, the use of the commercial AD-mix β was 
unsuccessful, and 4.89 was recovered quantitatively.  Osmylation of 4.89 with 
stoichiometric amounts of osmium tetroxide in pyridine provided the diol 4.90 in 40% 
yield (Scheme 4.29).170,171  When the N,N,N’,N’-tetramethylethylenediamine (TMEDA) 
ligated osmium tetroxide protocol of Donohoe,172 or the triethylamine variant,131 was 
used the diol 4.90 was obtained in 74% yield.  The ligation of the osmium tetroxide by 
the amine gave the dihydroxylating agent additional steric bulk and accordingly provides 
discrimination between the vinyl group and the less sterically accessible, but more 




















 With 4.90 available, the oxidative cleavage of the diol to the aldehyde 4.91 was 
explored.  Reaction of 4.89 with sodium periodate in either tetrahydrofuran/water or 
methanol/water provided a complex mixture (entries 1 and 2, Scheme 4.30).  The 1H-
NMR spectrum of the mixture contained several very minor peaks that may have 
corresponded to aldehydes.  The mass spectra did not have peaks that corresponded to the 
mass of 4.91.  To ensure that the product was not present, but not visible in either of the 
aforementioned spectra, the product mixtures were subjected to Pinnick oxidation 
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(NaClO2, NaH2PO4, 2-methyl-2-butene, not shown).173  The product mixtures from the 
Pinnick oxidation also lacked key signals for 4.92 in both the 1H-NMR spectrum, such as 
the alkenyl proton at C(9), and mass spectra.  Oxidation of 4.90 with lead tetraacetate 
also provided a complex mixture (entry 3). 
 Immobilizing sodium periodate on silica significantly increases the surface area, 
and thereby the reactivity of sodium periodate in non-aqueous solvent systems.174  The 
combination of sodium periodate and 2,6-di-tert-butylpyridine as a buffer in organic 
solvent is known to cleave simple diols rapidly and cleanly to their corresponding 
aldehydes.175  However, exposure of 4.90 to the NaIO4/SiO2 and buffer system provided a 
complex mixture of compounds (entry 4). 
 It appeared as though the cleavage of diol 4.90 occurred, but the product 4.91 
appeared to be unstable to the reaction conditions.  In an attempt to prevent this, the 
periodate cleavage of 4.90 was performed in the presence of sodium bicarbonate, and a 
Pinnick oxidation was performed immediately in the same reaction vessel (entry 5).  A 
complex mixture of products was again produced.  To further minimize the exposure time 
of 4.91 to the reaction conditions, 4.90 was subjected to both sodium periodate and the 
Pinnick reaction conditions at the same time, but the result was the same as sequential 
reaction (entry 6). 
 After the repeated failures to isolate any 4.91, 4.92, or 4.93 from the attempted 
oxidation of 4.90, the compatibility of the substrate with sodium periodate came into 
question.  To determine if there were any deleterious reactions other than the diol 
cleavage taking place, the diene 4.28 was subjected to sodium periodate cleavage 
conditions.  Because 4.28 was recovered in quantitative yield, it seemed likely that the 





entry reagents solvent temp. R product
1 NaIO4 THF/H2O 0 °C H complex mix.
2 NaIO4 MeOH/H2O 0 °C H complex mix.
3 Pb(Oc)4 PhH rt H complex mix.
4 NaIO4/SiO2, 2,6-di-t -Bu-pyridine THF rt H complex mix.
5
i . NaIO4, NaHCO3
ii . NaClO2, NaH2PO4, 2-methyl-2-butene




MeOH/H2O 0 °C OH complex mix.
7 IBX DMSO rt CH2OH no reaction
8 IBX, -cyβ clodextrin acetone/H2O rt CH2OH no reaction
9




   1. Δ
    2. 0 °C
CH2OH complex mix.
10 PDC CH2Cl2 rt CH2OH complex mix.
11 SO3·pyridine, NEt3, DMSO CH2Cl2 0 °C to rt CHO complex mix.  
 
There is very little discussion of lysergaldehyde (4.97), and no reports of its 
synthesis.  This absence is conspicuous due to the wealth of chemistry performed in the 
area of ergot alkaloids.  One of the few reports of chemistry dealing directly with a 
lysergaldehyde derivative was reported by Floss, who attempted to make lysergaldehyde 
(4.97) and Δ8,9-lysergaldehyde from elymoclavine (4.95) for biosynthetic studies.176  He 
found that oxidation of elymoclavine (4.96) was surprisingly difficult, and in a personal 
communication Hofmann disclosed to Floss that extensive research into oxidizing 
elymoclavine to lysergic acid had failed.  Floss’s best result was treatment of 
elymoclavine with acetic anhydride in dimethyl sulfoxide (Scheme 4.31).  The acetyl-
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enol ether of lysergaldehyde 4.96 was isolated in low yield.  All attempts to hydrolyze or 
oxidize the enol acetate of 4.97 failed, yielding only decomposition or complex mixtures. 
Scheme 4.31 






AgO (acidic or basic) OH
OH-, O2 OH
 
 Shough reported in a paper documenting synthetic studies towards 
lysergaldehydes that he was never able to synthesize either lysergaldehyde or Δ8,9-
lysergaldehyde.  Shough was able to transform 4.99 to aldehyde 4.100 in low yield, with 
C(10) tetrasubstituted to prevent enolization of α,β-unsaturated aldehyde 4.100 (Scheme 
4.32).  Neither Floss nor Shough shed any light on the pathway(s) of decomposition, but 
it is likely that lysergaldehydes were too unstable to be isolated and may have been too 

















To avoid the intermediacy of aldehyde 4.91, the syntheses of the hydroxy ketone 
4.93 and the glyoxal 4.94 were undertaken (Scheme 4.30).  Both hydroxy ketones and 
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glyoxals can be cleaved directly to the carboxylic acid without the intermediacy of an 
aldehyde.  When diol 4.90 was subjected to oxidation with o-iodoxybenzoic acid (IBX) 
in the presence of β-cyclodextrin, conditions shown by Rao to be effective at oxidizing 
1,2-diols selectively to hydroxy ketones, there was no visible reaction to afford 4.93 
(entry 8).177  Concomitantly, 4.90 was oxidized with IBX in the absence of β-
cyclodextrin (entry 7).  Unfortunately, neither oxidation appeared to consume 4.90, 
returning it untouched.  Oxidations with chromium-based reagents tends to oxidize 
secondary alcohols faster than primary alcohols, but pyridinium dichromate only 
decomposed 4.90 (entry 10).178  Another method of selectively oxidizing diols to hydroxy 
ketones was taken from sugar chemistry.  Initial formation of the stannylidene acetal of 
4.90, followed by treatment with N-bromosuccinimide should have provided 4.93 (entry 
9),179 but again only an intractable mixture was obtained.  The conditions of the Parikh-
Doering oxidation likewise destroyed 4.90 (entry 11).180
The hydroxy ketone 4.93 was still an attractive intermediate, but it was 
approached in a different fashion.  For example, diol 4.90 was mono-protected as the tert-
butyldimethylsilyl ether 4.101 (Scheme 4.33).  The crude product mixture was deemed 
sufficiently pure, so 4.101 was subjected to a Swern oxidation as well as oxidation with 
tetrapropylammonium perruthenate.  These reactions did not generate any 4.102; only 




 The Wacker oxidation is known for excellent selectivity in transforming terminal 
olefins into methyl ketones without oxidizing internal olefins in the same substrate.  
However, oxidation of diene 4.89 under a variety of conditions with stoichiometric 
palladium salts provided the same complex mixture of products and recovered 4.89 





 The most well known method for the oxidation of an olefin to a carboxylic acid 
derivative without the intermediacy of an isolable aldehyde is ozonolysis, and there are 
several useful methods for converting an olefin directly to an ester.  Ozonolysis of 4.89 
using the conditions of Marshall did not provide 4.95 or any other methyl ester (Scheme 
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4.35). 181  The only recognizable product was the N-oxide 4.104, whose identity was 
confirmed by both reduction to provide 4.89, and independent synthesis by oxidation of 
4.89 with 4-chloroperoxybenzoic acid (m-CPBA).  It is well known that more electron 
rich olefins react more readily with ozone while in solution.182  In an endeavor to make 
the vinyl substituent of 4.89 significantly more nucleophilic a cross metathesis with ethyl 
vinyl ether was attempted.  Molybdenum catalysts have worked poorly for cross 
metathesis with simple alkyl or aryl vinyl ethers, instead forming relatively unreactive 
Fischer carbene complexes upon metathesis with the vinyl ether.183  The very reactive 
second generation Grubbs catalyst was utilized for the metathesis, but only unreacted 













CH2CHOEt, Grubbs II 25% (4.70)
CH2Cl2, up to 55 °C
(sealed tube)
or








 When 4.90 was exposed to periodic acid in deuterated methanol, the result was 
interesting.  The reaction progress was monitored by 1H-NMR spectroscopy, and 4.90 
appeared to be consumed and form primarily one product (Scheme 4.37).  The 1H-NMR 
spectrum of the reaction mixture was consistent with the presence of 4.106.  When the 
reaction mixture was subjected directly to a Pinnick oxidation, it decomposed in an all 
too familiar fashion.  The low pH of the periodic acid cleavage must have been necessary 
to form the aldehyde hydrate, presumably the source of the stabilization of 4.106.  The 
buffered Pinnick oxidation was not sufficiently acidic, and as the pH increased the 






 The periodic acid cleavage of 4.90 was very exciting for two reasons.  It was the 
first evidence of a possible success in creating a carbonyl group or carbonyl surrogate 
from the diol.  The second reason was the convenient overlap with an interesting method 
for the oxidation of alcohols to acids developed recently by some researchers at Merck.  
They found that chromium trioxide could be used in catalytic amounts in the presence of 
stoichiometric amounts of periodic acid to oxidize primary alcohols to carboxylic acids 
and secondary alcohols to ketones.184  An artifact of using periodic acid as the 
stoichiometric oxidant was the preliminary cleavage of vicinal diols followed by the 
oxidation of the subsequent aldehyde to a carboxylic acid.  As an example they converted 




 The reaction between 4.90 and the periodic acid/chromium trioxide system was 
conducted in methanol to try to take advantage of possible Fischer esterification, 
hopefully providing 4.95 via 4.92 (Scheme 4.39).  Unfortunately neither of the desired 





 To avoid the intermediacy of unstable aldehyde 4.91, the late stages of the 
synthesis were modified.  The target lysergol (4.107) would be completed with late stage 
formation of the D ring via RCM (4.109 → 4.108, Scheme 4.40).  Diene 4.109 would 
come from the coupling of amine 4.46 with an electrophile already containing a protected 
carbinol with requisite stereochemistry.  If successful, the same approach would be 




 The alcohol 4.113 was made in the same manner as its known enantiomer, and 
transformed into bromide 4.110 (Scheme 4.41).185  Addition of the amine 4.46 to the 
bromide under the conditions that proved optimal for the homoallylation of 4.46 (4.7 → 
4.2, Scheme 4.2) at room temperature provided no reaction.  Elevating the temperature 





 Reductive amination of the aldehyde 4.111, which was a precursor of 4.113, and 
4.46 under several sets of conditions provided complex mixtures of products (Scheme 
4.42).  There was no 4.109, but there were inseparable mixtures of compounds that may 




NaBH(OAc)3 1,2-dichloroethane 4Å mol. sieves
NaBH(OAc)3 acetonitrile 4Å mol. sieves
NaBH(OAc)3 acetonitrile 4Å mol. sieves, AcOH
NaCNBH3 acetonitrile 4Å mol. sieves
NaCNBH3 acetonitrile 4Å mol. sieves, AcOH  
 
 Oxidation of aldehyde 4.111 to the acid 4.112 went smoothly in quantitative 
yield.  Peptide coupling of the amine 4.46 with the acid 4.112 did not give 4.113, instead 
generating 4.114 (Scheme 4.43).  Interestingly when 4.114 was exposed to lithium 
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aluminum hydride in an effort to selectively reduce the amide, a number of changes took 
place.  Instead of solely reducing the amide, the allylic silanol was completely removed, 
and the toluenesulfonyl protecting group of the indole was cleaved creating 4.116 
(Scheme 4.44).  While the allylic reduction would not have been an issue with 4.109, the 








 The appending of a fully developed portion of the D ring appeared untenable.  In 
an effort to return to the original goals of the synthesis while mediating potential 
problems the target penniclavine (4.117) was considered.  Penniclavine (4.117) could be 
made from 4.118 in the same fashion as was proposed for lysergol (4.107, Scheme 4.40).  
The problems encountered when attempting to synthesize aldehyde 4.91 would be 
minimized through the isolation of the aldehyde functionality by the tetrasubstituted 
center at C(8).  The D ring would be formed via asymmetric ring closing metathesis of 


























 Amine 4.46 underwent facile monoalkylation with ethylbromoacetate to give 
4.120 (Scheme 4.46).  Vinyl magnesium bromide added twice to the ester of 4.120, 
placing all of the needed elements to complete the synthesis.  Protection of the tertiary 
alcohol with tert-butyldimethylsilyl trifluoromethanesulfonate gave the ring closing 
metathesis precursor 4.119.  Remarkably 4.119 was completely inert to Schrock’s 
catalyst (4.15).  The most forcing conditions available, namely 300 watts of microwave 
irradiation in nonabsorbing solvent, yielded only recovered starting material. 
Substrate 4.27 would not undergo RCM using any prior technology, but the 
addition of microwave irradiation vastly improved the conversion of 4.27 to 4.28.  The 
addition of another substituent near the reaction center, namely the vinyl group of 4.119, 
halted even the microwave enhanced process.  It appeared as though the substrate 4.27 





 An expedient one carbon cleavage of 4.90 would greatly assist a total synthesis 
effort.  If the terminal carbon of the diol could be excised without the intermediacy of a 
carbonyl at the internal position, C(17), perhaps the total synthesis could be achieved.  
The most successful method for the removal of the terminal carbon was with periodic 
acid in methanol (Scheme 4.37).  The 1H-NMR of the reaction mixture illustrated that the 
carbinol was removed to provide a single compound, which was presumed to be 4.106, 
that was stable under the reaction conditions.  Oxidation of 4.103 failed, but reduction, if 





 Keeping the pH sufficiently low in the presence of a nucleophile, such as water or 
methanol, seemed to stabilize 4.106.  For the subsequent reduction, a reductant was 
needed that was both compatible with the acidic medium, and would maintain the 
necessary low pH.  The use of borohydrides in carboxylic acids for aldehyde reductions, 
has been studied and reviewed by Gribble.186  There are examples of diol cleavage 
followed by reduction of the aldehyde generated in situ with borohydrides, but none 
under acidic conditions.187  Gribble’s work showed that borohydride reductants were 
effective under acidic reaction conditions, so we reasoned that perhaps the combination 
of periodic acid and methanol, followed by borohydride would be effective. 
A general screen of cleavage and reduction conditions was performed on simple 
models, and periodic/acid borohydride combinations did indeed prove to be the best 
reagents for the transformation.  Application of the optimal reagent combinations to 4.90 
was performed on micro scale followed by examination of the 1H-NMR spectrum of the 
crude product mixture for key resonances H(9) and CH2OH (Scheme 4.48).  Treatment of 
4.90 with periodic acid followed by the addition of a large excess of sodium borohydride 
provided a complex mixture of compounds without any sign of 4.123.  The sodium 
borohydride may have neutralized the acid present in the mixture, leading to the large 
number of undesired compounds.  Addition of acetic acid as cosolvent and use of the 
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more acid tolerant sodium cyanoborohydride did provide a small amount of 4.123, in 
addition to several other compounds.  Unfortunately the reaction was difficult to 
reproduce and failed more often than it was successful.  Exchanging acetic acid (pKawater 
4.76) for the stronger trifluoroacetic acid (pKawater -0.25) provided the desired 4.123, and 
the crude product mixture was cleaner than the most successful attempt with acetic acid.  
Interestingly the use of trichloroacetic acid (pKawater 0.65) or methanesulfonic acid 
(pKawater -0.6), which are slightly less and slightly more acidic than trifluoroacetic acid 
respectively, failed to provide any significant amount of 4.123.  It is more likely that the 
failure of these alternate acids to provide 4.123 is due to the variability of the reaction 




reductant solvent target present?
NaBH4 MeOH no
NaCNBH3 AcOH, MeOH 0 to ~20%
NaBH4 MeOH, TFA yes
NaCNBH3 MeOH, TFA 54%
NaCNBH3 MeOH, TCA trace
NaCNBH3 MeOH, MeSO3H no
TFA = trifluoroacetic acid
TCA = trichloroacetic acid  
 
 For comparison to the synthetic material, an appropriately protected compound 
had been made from natural lysergol (4.107).  The straightforward synthesis was carried 
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out rapidly and without optimization with the sole purpose of providing N-tosyl lysergol 




 When the 1H-NMR spectrum of 4.126 from natural lysergol was compared to that 
of the synthetic 4.123, they did not match.  Both contained resonances characteristic of 
the lysergate family, but they were obviously different compounds.  Deprotection of 
synthetic 4.123 went smoothly to provide 4.122 again differing from lysergol (4.107), but 
including lysergate resonances.  Comparison with literature spectra and thin layer 





4.122 (this work) 4.122 (lit. value) 4.107 (lit. value)
H δ J (Hz) δ J (Hz) δ J
NH 7.94
14 7.17 5.1, 3.7 7.2a 7.36-7.10a
12-13 7.09-7.06
2 6.89 1.60 6.9 2 7 1.5
9 6.40 4.7 (br) 6.5 6 6.47 br s
CH2OH 3.82 10.3, 4.2 4.02 10, 3 3.66
3.71 10.3, 5.5, 0.7 3.86 10, 3, 2
4 beta 3.48 14.4, 5.5 3.54 15, 5.5 3.59 14, 6
5 beta 3.17 11.5, 5.5, 2.2 3.18 3.3
7 alpha 2.98 11.4, 1.8 3.07 11 3.2 11, 5
7 beta 2.77 11.4, 3.8 2.87 11, 3.5, 2 2.39 11, 11
4 alpha 2.63 14.4, 11.5, 1.7 2.68 15, 12, 2 2.74 14, 12, 1.5
NMe 2.53 2.56 2.64
8 2.5-2.45 2.46 2.92
a  C(12-14)H  
 
 The isolysergol stereochemistry was expected due to the nOe data gathered from 
4.28 and 4.89.  If the stereochemical assignment of 4.28 and 4.89 had been incorrect, 
however, we may still have seen iso geometry in the product if C(8) epimerized during 
the cleavage sequence.  If the product of the cleavage 4.127 had enolized, it could have 





 It was unlikely that enolization was taking place to any great extent.  If 
enolization was taking place both epimers 4.123 and 4.126, and/or the Δ8,9 analogs should 
have been formed analogous to the equilibrium mixtures seen in all of the methyl 
lysergate and lysergic acid analogs (vide supra).  To prove that this was not taking place 
another method was used to remove the extra carbon of 4.90.  Cleaving of the carbon via 
deformylation would remove the possibility of epimerization at C(8), and could be useful 
both as a mechanistic probe of the oxidative cleavage/reduction of 4.90 and as a 
structural proof of the product of the asymmetric ring closing metathesis 4.28.191  
Isolysergol (4.107) could be obtained from protected 4.130, which would be the 





 The installation of both silyl ethers on 4.90 was sluggish, but selective removal of 
the terminal protecting group was quite facile (Scheme 4.53).  Swern oxidation of 4.133 
proceeded well to give 4.131, which was carried on with minimal purification.  
Deformylation of 4.131 was performed with a stoichiometric quantity of Wilkinson’s 
catalyst, yielding a small amount of 4.130.  Upon comparison of the 1H-NMR spectra it 




 When 4.133 was compared to the silyl ether of 4.123, however, they were found 
to be identical (Scheme 4.54).  Therefore the original stereochemical assignment of 4.28 
was correct, and additional support was gained for the lack of the enolization process 
















 Based upon the available information, there is no reasonable way to determine the 
cause of the formation of the diastereomer 4.28 during the RCM of 4.27.  Different 
catalysts (4.15, R/S-4.23) all favored the isolysergate stereochemistry, which would imply 
substrate control was in effect.  Without any isolable intermediates or spectral evidence, 
only supposition based on the observed products and the slight preference for iso 
geometry was available. 
Catalysts such as 4.134 are Lewis acidic enough at the molybdenum center that 
they are isolated as their tetrahydrofuran or pyridine adducts (Figure 4.6).  A potential 
reason for the apparent substrate control of the RCM may be that the basic amine of 4.27 
is coordinating the RCM catalyst to generate a complex such as 4.135.  If this were the 
case the large, sterically demanding, catalyst would likely be disposed towards the most 
open area in the vicinity of the amine, the top of the tricycle as drawn.  This positioning 
of the spatially demanding catalyst might force the pentadienyl moiety down and away 
from the catalyst, perhaps as drawn.  Regardless of the specifics of the positioning of the 
catalyst and pentadiene, they would be sufficiently far away from each other to react with 
any facility.  If this were the case the complex could not only impede the formation of the 
alkylidene leading to one or the other stereoisomer, it would explain the need for large 
catalyst loads and forcing conditions to produce any reaction.  However 4.135 is 
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sufficiently complicated that it was unreasonable to make any stereochemical predictions 




 Another rationale for the preference of 4.89 over 4.28 would be the loading of the 
catalyst on the 1,1-disubstituted olefin of 4.27, rather than either of the two vinyl groups. 
Another proposition for the RCM was that the catalyst loaded on the 1,1-disubstituted 
olefin of 4.27, rather than either of the two vinyl groups.  If the catalyst were to load on 
one of the vinyl substituents first, the event would be the stereo determining step.  There 
is quite a bit of flexibility in the σ-bonds between the diastereomeric vinyl groups of 4.27 
and the tricyclic core.  It is not immediately apparent whether there would be a preference 
for loading of the catalyst on one versus the other (Figure 4.7).  Once the catalyst has 
loaded on to an olefin only one of the two possible diastereomers can form.  The 
preference shown between 4.28 and 4.89 was slight, but there seems to be little reason to 
believe there would be any preference at all between the loading of one vinyl substituent 





Conversely, if the catalyst were to load on the 1,1-disubstituted olefin the 
stereochemical determining step would be the approach of one of the vinyl groups to the 
molybdenum-substrate carbene.  Some possible approach trajectories are shown in Figure 
4.8.  This mode of reactivity and stereoselection is what has been proposed as the source 
of the high enantioselectivities in ARCM reactions of substrates such as 4.22 (Equation 
3). 
The two approaches A and B appear to be slightly favored versus C or D.  Of the 
two more favored trajectories A, with the extra vinyl group disposed down as drawn, 
would have more clearance between the alkene and the ligands on the molybdenum than 
B with the vinyl group up as drawn.  Again this is only supposition, and the trajectories 








4.3 CONCLUSIONS  
 Isolysergol has been synthesized in an enantiocontrolled fashion in 12 
operations from commercially available starting materials.  Both of the chiral centers 
were installed by employing chiral catalysts, and there were relatively few oxidation state 
modifications throughout the molecule 
Prior to the current work only Szántay had synthesized an enantiomerically 
enriched lysergate, and a lysergate containing both a C(2)-C(3) double bond for the entire 
synthesis and unambiguous installation of the C(9)-C(10) double bond, as opposed to an 
equilibrating/isomerizing method of moving the bond into final position.  In fact only 
Woodward and Szántay installed the C(9)-C(10) double bond with specificity, both using 
essentially the same method. 
The indole core of the present work was present from the commercially available 
starting material and remained intact the completion of the synthesis without the need to 
reduce or otherwise protect the C(2)-C(3) π-bond.  The C(9)-C(10) olefin was installed in 
a discrete fashion using RCM and, likewise, remained until the completion of the 
synthesis. 
Not only did the RCM form the D ring and install the olefin in analogous fashion 
to Szántay and Woodward, but use of olefins for the installation removed potential issues 
with the carbonyl groups used by Woodward and Szántay.  Without the carbonyl present 
the C(5) chiral center could be set and maintained without fear of racemization during the 
condensation to form the D ring.  This set the stage for an enantioselective formation of 
R-4.37 instead of the inherently less efficient resolution employed by Szántay. 
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While the key ARCM was not able to produce both the normal and the iso 
stereochemistry, it was still a triumph of RCM technology.  The surprising difficulty 
encountered in performing the RCM on 4.27 provoked the development of a novel 
combination of molybdenum metathesis catalysis and microwave heating.  This new 
combination may find use in other RCM reactions.  Reports of similarly difficult RCM 
transformations are conspicuously absent from the literature, but that may be due to 
solely to the lack of publications covering failed chemistry.  Furthermore the ring closure 
of 4.27 to 4.28 with the chiral catalyst S-4.20 represents the first use of a chiral 
metathesis catalyst on an advanced substrate.  Although 4.28 was of the unplanned 
diastereomeric configuration this example shows some of the potential of the relatively 
young field of catalytic asymmetric ring closing metathesis in that it is indeed applicable 
to late stage transformations on advanced, functionality laden, compounds.  Additionally 
this work represents the first example of any significant favoritism for the iso 
stereochemistry in the synthesis of a lysergate, an outcome that may, one day, find use in 
synthesizing analogs for pharmaceutical testing. 
The excision of the terminal carbinol of 4.90 via the exceedingly sensitive 
presumed intermediate 4.106 avoiding the completely intractable 4.91 was accomplished.  
After many false starts success came via the coupling of very dissimilar methodologies, 
namely oxidation and reduction in strong acid, to provide a technically very simple 
method to rapidly cleave a terminal diol to an alcohol in one pot.  These extreme 
conditions won’t be useful for the same transformation on a wide array of substrates, but 
may prove invaluable for similarly sensitive aldehydes. 
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Chapter 5:  Experimental Procedures 
5.1 GENERAL METHODS 
Unless otherwise indicated, all starting materials were obtained from commercial 
suppliers and used without further purification.  The (S)-Schrock-Hoveyda catalyst (4.20) 
was stored below -30 °C in a nitrogen filled glove box, and weighed into septum sealed 
vials before removal from the glove box.  Methanol (MeOH), acetonitrile (CH3CN), and 
N,N-dimethylformamide (DMF) were dried by passage through two columns of activated 
molecular sieves.  Toluene was dried by passage through a column of activated neutral 
alumina followed by passage through a column of Q5 reactant.  Tetrahydrofuran (THF) 
was dried by passage through two columns of activated neutral alumina.  Benzene (PhH) 
was distilled from sodium and benzophenone under an atmosphere of nitrogen 
immediately prior to use.  Triethylamine (NEt3) was distilled from CaH2 under an 
atmosphere of nitrogen immediately prior to use.  Methylene chloride (CH2Cl2) was 
distilled from CaH2 under an atmosphere of nitrogen immediately prior to use.  Reactions 
involving air or moisture sensitive reagents or intermediates were carried out under an 
inert atmosphere of nitrogen or argon in glassware that had been oven dried, flame dried, 
or dried via repeated evacuation (<0.2 mm Hg) followed by nitrogen purge.  Reaction 
temperatures are reported as the temperature of the bath surrounding the vessel.  
Microwave reactions were carried out in a CEM Discovery single mode microwave 
reactor with stirring via magnetic stir bar.  Flash chromatography was conducted 
according to the established Still protocol using ICN Biomedicals ICN-SILITech 32-63d 
silica gel with the indicated solvents.192  All NMR spectra were taken on a Bruker AC 
250, General Electric QE-300, Varian Mercury 400, or Varian INOVA 500 instrument in 
deuterated chloroform (CDCl3) unless otherwise noted.  Chemical shifts (δ) are 
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expressed as ppm referenced to the residual solvent (i.e. chloroform, 7.24 ppm).  Splitting 
patterns are expressed as s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; m, multiplet; 
comp, complex multiplet; br, broad; app, apparent.  High resolution mass spectra were 
taken on VG Analytical ZAB2-E instrument. 




one (2.27).  
Method A: (JD 1-166). Carbon tetrabromide (42 mg, 0.13 mmol) was sublimed at 100 
°C (<1 mmHg) to the sides of a borosilicate glass vial.  The vessel was flushed with N2, 
and 2.20 (290 mg, 0.504 mmol) in dry MeOH (1.75 mL) was added via cannula.  The 
vessel was sealed and heated to 100 °C with stirring for 1.5 h.  The mixture was cooled to 
room temperature, concentrated under reduced pressure, and the residue purified via flash 
chromatography eluting with MeOH/CH2Cl2 (1-4%) to yield 112 mg (49%) of 2.27 and 
60 mg (21%) of 2.20. 
Method B: (JD 1-179, 1-184, 1-185). A solution of 2.30 (44 mg, 0.14 mmol) in dry 
toluene (15 mL) was heated at 115 °C for 26 h.  The solution was concentrated under 
reduced pressure and the residue dissolved in CH2Cl2/H2O (20:1, 1.6 mL).  2,3-Dichloro-
5,6-dicyano-1,4-benzoquinone (DDQ) (28 mg, 0.12 mmol) was carefully added 
portionwise with stirring over the course of 1 h until no starting material remained.  
Saturated aqueous NaHCO3 (1 mL) and EtOAc (2 mL) were added, and the layers were 
separated.  The aqueous layer was washed with EtOAc (3 X 2 mL), and the combined 
organic layers were dried (Na2SO4).  The solution was filtered through a pad of silica 
(deactivated with triethylamine) washing with EtOAc, concentrated under reduced 
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pressure, and the residue was dissolved in dry toluene (0.5 mL). TIPS protected 
tryptamine 2.21 (21 mg, 0.066 mmol) and 4 Å molecular sieves were added, and the 
mixture was heated at 115 °C for 4 h.  The mixture was cooled, and MeOH (0.5 mL) and 
NaBH4 (5 mg, 0.13 mmol) were added.  The mixture was stirred for 24 h whereupon 
saturated aqueous NaHCO3 (0.5 mL) and EtOAc (0.5 mL) were added, the layers were 
separated, the aqueous layer was washed with EtOAc (3 X 0.5 mL), and the combined 
organic layers were dried (Na2SO4).  The solution was concentrated under reduced 
pressure, and the residue purified via flash chromatography eluting with MeOH/CH2Cl2 
(2-3%) to yield 13 mg (20%) of 2.27.  1H NMR δ 7.60-7.57 (m, 1 H), 7.47-7.43 (m, 1 H), 
7.15-7.06 (comp, 2 H), 7.05 (s, 1 H), 6.00-5.55 (comp, 2 H), 4.07 (br d, J = 3.5 Hz, 2 H), 
3.64 (t, J = 7.3 Hz, 2 H), 3.15-2.95 (comp, 4 H), 2.55-2.30 (comp, 2 H), 2.15 (dd, J = 
10.0, 16.4 Hz, 1 H), 1.77-1.59 (comp, 4 H), 1.50-1.30 (m, 1 H), 1.11 (d, J = 7.5 Hz, 18 
H); 13C NMR δ 168.9, 141.2, 133.6, 131.0, 129.0, 128.7, 121.4, 119.3, 118.5, 115.0, 
113.9, 63.1, 48.1, 47.6, 38.0, 35.3, 28.9, 23.0, 18.1, 12.7; IR (neat) 3382, 3046, 2946, 
2867, 1621; MS CI+ m/z 455.3090 [C27H43N2O2Si (M+1) requires 455.3094] (base), 
437, 411. 
NMR Assignments.  1H NMR δ 7.60-7.57 (m, 1 H, C13-H or C16-H), 7.47-7.43 (m, 1 
H, C13-H or C16-H), 7.15-7.06 (comp, 2 H, C14-H, C15-H), 7.05 (s, 1 H, C18-H), 6.00-
5.55 (comp, 2 H, C2-H, C3-H), 4.07 (br d, J = 3.5 Hz, 2 H, C1-H), 3.64 (t, J = 7.3 Hz, 2 
H, C9-H), 3.15-2.95 (comp, 4 H, C7-H, C10-H), 2.55-2.30 (comp, 2 H, C4-H, C5-Ha), 
2.15 (dd, J = 10.0, 16.4 Hz, 1 H, C5-Hb), 1.77-1.59 (comp, 4 H, C8-Ha, C19-H), 1.50-
1.30 (m, 1 H, C8-Hb), 1.11 (d, J = 7.5 Hz, 18 H, C20-H); 13C NMR δ 168.9 (C6), 141.2 
(C17), 133.6 (C3), 131.0 (C12), 129.0 (C2), 128.7 (C18), 121.4 (C14), 119.3 (C15), 
118.5 (C13), 115.0 (C11), 113.9 (C16), 63.1 (C1), 48.1 (C9), 47.6 (C7), 38.0 (C5), 35.3 





(2.32). (JD 1-133).  Tributylphosphine (0.070 mL, 0.28 mmol) was added to a stirred 
solution of i-Pr2NEt (ca 0.025 mL, 0.14 mmol) in dry CCl4 (1 mL) and an exotherm was 
observed.  After 30 s the solution was added via cannula to a stirred solution of 2.27 (33 
mg, 0.073mmol) in dry CH2Cl2 (1 mL).  The reaction was stirred for 5 min whereupon 
saturated aqueous NaHCO3 (1 mL) was added, and the layers were separated.  The 
aqueous layer was washed with CH2Cl2 (3 X 1 mL), and the combined organic layers 
were dried (Na2SO4). The solution was concentrated under reduced pressure, and the 
residue was filtered through a pad of silica washing with EtOAc to remove 
tributylphosphine oxide.  The solution was again concentrated under reduced pressure, 
and the residue was purified via flash chromatography eluting with MeOH/CH2Cl2 (1%) 
to yield 33 mg (96%) of 2.32.  1H NMR δ 7.60-7.57 (m, 1 H), 7.47-7.43 (m, 1 H), 7.15-
7.06 (comp, 2 H), 7.05 (s, 1 H), 5.61-5.57 (comp, 2 H), 3.98 (d, J = 5.8 Hz, 2 H), 3.65 (t, 
J = 6.5 Hz, 2 H), 3.12-2.95 (comp, 4 H), 2.55-2.30 (comp, 2 H), 2.16 (dd, J = 9.6, 16.2 
Hz, 1 H), 1.67 (comp, 4 H), 1.43 (m, 1 H), 1.11 (d, J = 7.5 Hz, 18 H); 13C NMR δ 169, 
141.2, 136.9, 131.0, 128.7, 125.8, 121, 119.4, 118.6, 115, 114.0, 48.2, 47.4, 44.8, 37.7, 
35.2, 28.6, 23.0, 18.1, 12.8; IR (neat) 2950, 2925, 2867, 1625.4; MS CI+ m/z 473.2743 
[C27H42N2OSiCl (M+1) requires 473.2755] (base), 437. 
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NMR Assignments.  1H NMR δ 7.60-7.57 (m, 1 H, C13-H or C16-H), 7.47-7.43 (m, 1 
H, C13-H or C16-H), 7.15-7.06 (comp, 2 H, C14-H, C15-H), 7.05 (s, 1 H, C18-H), 5.66-
5.60 (comp, 2 H, C2-H, C3-H), 3.88 (d, J = 6.5 Hz, 2 H, C1-H), 3.65 (dd, J = 7.0, 3.3 Hz, 
2 H, C9-H), 3.15-2.95 (comp, 4 H, C7-H, C10-H), 2.55-2.30 (comp, 2 H, C4-H, C5-Ha), 
2.16 (dd, J = 9.3, 16.0 Hz, 1 H, C5-Hb), 1.80-1.55 (comp, 4 H, C8-Ha, C19-H), 1.43 (m, 
1 H, C8-Hb), 1.11 (d, J = 7.5 Hz, 18 H, C20-H); 13C NMR δ 169(C6), 141.2 (C17), 
136.9 (C3), 131.0 (C12), 128.7 (C18), 125.8 (C2), 121 (C14), 119.4 (C15), 118.6 (C13), 
115 (C11), 114.0 (C16), 48.2 (C9), 47.4 (C7), 44.8 (C1), 37.7 (C5), 35.2 (C8), 28.6 (C4), 





yl)ethyl]piperidin-2-one (2.36). (JD 1-113).  LiSnBu3 was formed using the method of 
Still193 [n-BuLi (0.69 mL of 1.47 M in hexane, 1.0 mmol) was added to a stirred solution 
of diisopropylamine (0.17 mL, 1.2 mmol) in THF (3.88 mL) at 0 °C under N2 in a flame 
dried vial, and stirred for 30 min.  Freshly distilled tributyltin hydride (0.27 mL, 0.10 
mmol) was added to the LDA.  The solution was stirred for 15 min to form 5 mL of 0.2 
M LiSnBu3.]  LiSnBu3 (ca 1.8 mL of 0.2 M in THF, 0.3 mmol) was added via cannula to 
a solution of 2.32 (77 mg, 0.16 mmol) in dry THF (1 mL) at –78 °C under N2.  After 5 
min the reaction was warmed to 0 °C, H2O (1 mL) and EtOAc (1 mL) were added, and 
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the layers were separated.  The aqueous layer was washed with EtOAc (3 X 1 mL) and 
the combined organic layers were dried (Na2SO4).  The mixture was concentrated under 
reduced pressure, dissolved in EtOAc and filtered through a pad of silica gel washing 
with EtOAc.  The mixture was again concentrated under reduced pressure and the residue 
held at low pressure (<1 mm Hg) for 14 h.  The residue was purified via flash 
chromatography eluting with EtOAc/hexanes (5-10%) to yield 89 mg (75%) of 2.36.  1H 
NMR δ 7.61-7.52 (m, 1 H), 7.47-7.43 (m, 1 H), 7.15-7.08 (comp, 2 H), 7.04 (s, 1 H), 5.52 
(dt, J = 15.3, 7.5 Hz, 2 H), 5.05 (dd, J = 6.5, 15.3 Hz, 1 H), 3.64 (m, 2 H), 3.15-2.95 
(comp, 4 H), 2.55-2.40 (m, 1 H), 2.40-2.20 (m, 1 H), 2.17 (dd, J = 10.5, 16.4 Hz, 1 H), 
1.80-1.20 (comp, 20 H), 1.11 (d, J = 7.5 Hz, 18 H), 1.00-0.75 (m, 15 H);  13C NMR δ 
169.4, 141.3, 131.0, 129.3, 128.8, 127.4, 121.4, 119.3, 118.6, 115.1, 114.0, 48.0, 47.8, 
38.9, 36.0, 29.7, 29.1, 27.3, 23.1, 18.1, 14.2, 13.7, 12.8, 9.1; IR (neat) 2952, 2924, 2868, 
1643; MS CI+ m/z 729.4206 [C39H69N2OSi120Sn (M+1) requires 729.4201] 727, 439, 
291 (base), 287. 
NMR Assignments.  1H NMR δ 7.61-7.52 (m, 1 H, C17-H or C20-H), 7.47-7.43 (m, 1 
H, C17-H or C20-H), 7.15-7.08 (comp, 2 H, C18-H, C19-H), 7.04 (s, 1 H, C22-H), 5.52 
(dt, J = 15.3, 7.5 Hz, 2 H, C6-H), 5.05 (dd, J = 6.5, 15.3 Hz, 1 H, C7-H), 3.64 (m, 2 H, 
C13-H), 3.15-2.95 (comp, 4 H, C11-H, C14-H), 2.55-2.40 (m, 1 H, C9-Ha), 2.40-2.20 
(m, C8-H, 1 H), 2.17 (dd, J = 10.5, 16.4 Hz, 1 H, C9-Hb), 1.80-1.20 (comp, 20 H, C2-H, 
C3-H, C8-H, C9-H, C12-H, C23-H), 1.11 (d, J = 7.5 Hz, 18 H, C24-H), 1.00-0.75 (m, 15 
H, C1-H, C4-H); 13C NMR δ 169.4 (C10), 141.3 (C21), 131.0 (C16), 129.3 (C7), 128.8 
(C27), 127.4 (C6), 121.4 (C18), 119.3 (C19), 118.6 (C17), 115.1 (C15), 114.0 (C20), 
48.0 (C13), 47.8 (C11), 38.9 (C9), 36.0 (12), 29.7 (C8), 29.1 (C3), 27.3 (C2), 23.1 (C14), 





indol-3-yl)ethyl]piperidin-2-one (2.37).  (JD-171).  A 0.48 M solution of LDA (0.93 
mL, 0.45 mmol) in a flame dried vial was cooled to –78 °C, and a –78 °C solution of 2.36 
in THF (1 mL) was added via cannula.  After ca 1.5 h excess freshly distilled 
acetaldehyde was added via cannula, and the solution was stirred for 15 min.  The 
solution was warmed to rt for 15 min and then recooled to 0 °C whereupon 0.5 M H2SO4 
(2 mL) and EtOAc (2 mL) were added.  The layers were separated, and the organic layer 
was washed with EtOAc (3 X 2 mL).  The combined organic layers were washed with 
saturated NaHCO3 (2 mL) and dried (NaSO4). The mixture was concentrated under 
reduced pressure, dissolved in EtOAc, and filtered through a pad of silica gel washing 
with EtOAc.  The mixture was again concentrated under reduced pressure and held at low 
pressure (<1 mm Hg) for 14 h.  The residue was purified via flash chromatography 
eluting with EtOAc/hexanes (5-20%) to yield 140 mg (81%) of 2.37.  1H NMR δ 7.65-
7.55 (m, 1 H), 7.47-7.43 (m, 1 H), 7.15-7.08 (comp, 2 H), 7.05 (s, 1 H), 5.58 (dt, J = 
14.8, 7.9 Hz, 1 H), 5.04 (dd, J = 8.0, 15.1 Hz, 1 H), 4.04 (d, J = 5.9 Hz, 1 H), 3.92 (q, J = 
5.9 Hz, 1H), 3.70-3.55 (m, 2 H), 3.12-2.97 (comp, 4 H), 2.45-2.25 (m, 1 H), 2.11-2.02 
(m, 1 H), 1.80-1.55 (comp, 7 H), 1.55-1.35 (comp, 7 H), 1.35-1.20 (comp, 10 H), 1.11 (d, 
J = 7.5 Hz, 18 H), 1.00-0.75 (m, 15 H); 13C NMR δ 171.5, 141.3, 131.1, 130.9, 128.8, 
 134
127.6, 121.5, 119.4, 118.5, 114.9, 114.0, 68.72, 53.0, 48.6, 46.8, 38.8, 36.0, 29.1, 27.3, 





3-yl)ethyl]piperidin-2-one (2.19).  (JD 1-172).  Copper chloride (3 mg, 0.03 mmol) and 
2.37 (23 mg, 0.030 mmol) were suspended in a stock solution of DCC in toluene (0.15 
mL, 0.25 M, 0.038 mmol).  The mixture was heated with stirring to 100 °C for 3 h., 
cooled to rt and saturated aqueous NaHCO3 (1 mL) was added.  The layers were 
separated, the aqueous layer was washed with EtOAc (3 X 1 mL), and the combined 
organic layers were dried (Na2SO4).  The mixture was concentrated under reduced 
pressure, and the residue was purified via flash chromatography eluting with 
EtOAc/hexanes (5-20%) to yield 5 mg (22%) of E-2.19, 10 mg (44%) of Z-2.19, and 2 
mg (9%) of 2.37.  E-2.19 1H NMR δ 7.62-7.57 (m, 1 H), 7.47-7.43 (m, 1 H), 7.15-7.06 
(comp, 3 H), 5.85 (dq, J = 6.0, 1.3 Hz, 1 H), 5.51 (dt, J = 15.1, 8.5 Hz, 1 H), 5.10 (dd, J = 
15.1, 6.9 Hz, 1 H), 3.86-3.70 (m, 1 H), 3.61-3.45 (m, 1 H), 3.30-2.86 (comp, 5 H), 2.17 
(dd, J = 6.0, 1.1 Hz, 3 H), 1.82-1.16 (comp, 19 H), 1.10 (d, J = 7.5 Hz, 18 H), 0.97-0.68 
(comp, 15 H).  Z-5 1H NMR δ 7.64-7.60 (m, 1 H), 7.47-7.42 (m, 1 H), 7.14-7.00 (comp, 
3 H), 5.45 (dt, J = 16.5, 8.5 Hz, 1 H), 5.10 (dd, J = 15.1, 5.2 Hz, 1 H), 3.92-3.80 (m, 1 H), 
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3.64-3.42 (comp, 3 H), 3.08-2.89 (comp, 3 H), 1.85-1.16 (comp, 21 H), 1.10 (d, J = 7.5 





one (2.50).  (JD 1-221).  Tetrabutylammonium fluoride (TBAF) (0.036 mL, 0.037 mmol, 
1 M in THF) was added to a stirred solution of 2.19 (23 mg, 0.031 mmol) in THF (0.35 
mL) cooled to 0° C via syringe.  The reaction was stirred 5 min whereupon saturated 
aqueous NaHCO3 (0.5 mL) was added, the mixture was warmed to rt, and the layers were 
separated.  The aqueous layer was washed with EtOAc (3 X 1 mL), and the combined 
organic layers were dried (Na2SO4). The solution was filtered through a pad of silica 
washing with EtOAc, concentrated under reduced pressure, and the residue was purified 
via flash chromatography eluting with EtOAc/hexanes (40%) to yield 18 mg (99%) of 
2.50.  1H NMR (250 MHz) δ 8.09 (s br, 1 H), 7.65 (d, 1 H), 7.34 (d, 1 H), 7.20-7.03 
(comp, 3 H),  5.86 (q, J = 7.3 Hz, 1 H), 5.53 (dt, J = 15.0, 8.5 Hz, 1 H), 5.11 (dd, J = 
15.0, 6.8 Hz, 1 H), 3.71-3.69 (m, 2 H), 3.35-2.90 (m, 5 H), 2.17 (d, J = 6.9 Hz, 3 H), 
1.95-1.17 (comp, 16 H), 0.97-0.68 (comp, 15 H); 13C NMR (250 MHz) δ 165.3, 136.3, 
136.1, 132.5, 131.3, 127.5, 126.0, 122.0, 121.9, 119.3, 118.9, 113.6, 111.1, 48.3, 46.2, 
44.4, 29.6, 29.2, 27.3, 23.1, 17.7, 16.0, 14.4, 13.7, 12.3, 9.2 
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NMR Assignments.  1H NMR (250 MHz) δ 8.09 (s br, 1 H, N-H), 7.65 (d, 1 H, C19-H 
or C22-H), 7.34 (d, 1 H, C19-H or C22-H), 7.20-7.03 (comp, 3 H, C20-H, C21-H, C23-
H), 5.86 (q, J = 7.3 Hz, 1 H, C13-H), 5.53 (dt, J = 15.0, 8.5 Hz, 1 H, C6-H), 5.11 (dd, J = 
15.0, 6.8 Hz, 1 H, C7-H), 3.71-3.69 (m, 2 H, C15-H), 3.35-2.90 (m, 5 H, C8-H, C11-H, 
C16-H), 2.17 (d, J = 6.9 Hz, 3 H, C14-H), 1.95-1.17 (comp, 16 H, C2-H, C3-H, C5-H, 




3-(1-Hydroxyethyl)-5,6-dihydropyran-2-one (2.64).  (JD 2-203).  A mixture of 5,6-
dihydropyran-2-one (2.60, 1.00 g, 10.2 mmol) and freshly distilled acetaldehyde (0.859 
mL, 15.3 mmol) in THF (35 mL) was added slowly dropwise via syringe over 30 min to 
a stirred solution of lithium phenylselenide (6.22 mmol).85  After 1 h the mixture was 
warmed to –20 °C for 2 h whereupon saturated aqueous NaHCO3 (50 mL) and EtOAc 
(50 mL) were added.  The layers were separated, the aqueous layer was washed with 
EtOAc (3 X 50 mL), and the combined organic layers were dried (Na2SO4).  The mixture 
was concentrated under reduced pressure and the residue was purified via flash 
chromatography eluting with EtOAc/hexanes (50-75%) to yield 1.029 g (71%) 2.64 and 
58 mg (6%) of impure 5,6-dihydropyran-2-one.  1H-NMR (250 MHz) δ 6.83 (t, J = 4.2 
Hz, 1 H), 4.60-4.50 (m, 1 H), 4.34 (t, J = 6.3, 2 H), 3.10-3.05 (m, 1 H), 2.49-2.40 (m, 2 
H), 1.34 (d, J = 6.5 Hz, 3 H); 13C-NMR δ 164.8, 138.7, 135.7, 66.3 (66.326), 66.3 
(66.260), 23.9, 21.6; MS CI+ m/z 143.0713 [C7H11O3 (M+1) requires 143.0708] (base), 
125, 157, 285. 
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NMR Assignments.  1H-NMR (250 MHz) δ 6.80 (t, 1 H, C3-H), 4.60-4.50 (m, 1 H, C6-
H), 4.34 (t, 2 H, C1-H), 3.10-3.05 (m, 1 H, OH), 2.49-2.40 (m, 2 H, C2-H), 1.34 (d, 3 H, 
C7-H); 13C-NMR δ 164.8 (C5), 138.7 (C3), 135.7 (C4), 66.3 (66.326) (C1), 66.3 
















1-(2-Oxo-5,6-dihydro-2H-pyran-3-yl)ethyl acetate (2.59).  (JD 2-297).  Pyridine (1.14 
mL, 14.1 mmol) was added to a solution of 2.64 (1.00 g, 7.05 mmol) and 4-
dimethyaminopyradine (86 mg, 0.71 mmol) in dry CH2Cl2 (35 mL) cooled to 0 °C.  
Acetyl chloride (0.752 mL, 10.6 mmol) was added dropwise via syringe; and the mixture 
immediately became flocculent.  The mixture was stirred for 75 min whereupon 1 M HCl 
(50 mL) was added.  The layers were separated and the aqueous layer was washed with 
CH2Cl2 (3 X 50 mL).  The combined organic layers were washed with saturated aqueous 
NaHCO3 (50 mL) and dried (Na2SO4).  The solution was concentrated under reduced 
pressure and the residue was purified via flash chromatography eluting with 
EtOAc/hexanes (50-66%) to yield 1.26 g (97%) of 2.59.  1H-NMR (250 MHz) δ 6.83 (t, J 
= 4.2 Hz, 1 H), 5.61 (qd, J = 6.5, 1.1 Hz, 1H), 4.29 (t, J = 6.3, 2 H), 2.42 (q, J = 6.25, 1 
H), 1.99 (s, 3 H), 1.33 (d, J = 6.5 Hz, 3 H). 
NMR assignments.  1H-NMR (250 MHz) δ 6.83 (t, J = 4.2 Hz, 1 H, C3-H), 5.61 (qd, J = 
6.5, 1.1 Hz, 1H, C6-H), 4.29 (t, J = 6.3, 2 H, C1-H), 2.42 (q, J = 6.25, 1 H, C2-H), 1.99 





3-Ethylidene-4-vinyltetrahydropyran-2-one (2.58).  (JD 3-78).  CuCN (103 mg, 1.15 
mmol) was dried via alternating evacuation/N2 purge (two cycles), THF (50 mL) was 
added via syringe, the slurry was cooled to –78 °C, and a stock solution of 
vinylmagnesium bromide (7.34 mL, 1.57 M, 11.5 mmol) was added dropwise via syringe 
with stirring.  The mixture was stirred for 1 h, the -78 °C bath was exchanged for a 0 °C 
bath for 10 min, and the dark solution was then re-cooled to –78 °C.  A portion of the 
solution of divinyl cuprate thus made (35 mL, ~1.2 eq) was added dropwise to 2.59 
(1.062 g, 5.77 mmol) in dry THF (50 mL) cooled to -78 °C.  The mixture was stirred for 
45 min and then poured into saturated aqueous NH4Cl (100 mL).  The resulting mixture 
was stirred for 30 min, whereupon EtOAc (50 mL) and enough H2O to dissolve the 
formed white precipitate were added.  The layers were separated, the aqueous layer was 
washed with EtOAc (3 X 50 mL), the combined organic layers were dried (Na2SO4), 
concentrated under reduced pressure, and the residue was purified via flash 
chromatography eluting with EtOAc/hexanes (20%) to yield 737 mg (73%) of 2.58.  1H 
NMR (400 MHz) δ 7.30 (qd, J = 7.7 & 1.3, overlaps with CHCl3), 5.76 (ddd, J = 17.2 & 
10.3 & 5.2, 1 H), 5.19 (dd, J = 9.6 & 1.4, 1 H), 5.00 (dt, J = 17.2 & 1.5, 1 H), 4.32 (td, J 
= 11.0 & 2.7, 1 H), 4.25-4.19 (m, 1 H), 3.60-3.48 (m, 1 H), 2.22-2.0 (m, 1 H), 1.84-1.73 
(comp, 4 H); 13C-NMR δ 166.3, 143.8, 136.7, 127.2, 117.0, 64.9, 36.5, 28.4, 14.3; MS 
CI+ m/z 153.0909 [C9H13O2 (M+1) requires 153.0916] (base), 97, 154, 305. 
NMR assignments.  1H NMR (400 MHz) δ 7.30 (qd, overlaps with CHCl3, C6-H), 5.76 
(ddd, 1 H, C8-H), 5.19 (dd, 1 H, C9-H E), 5.00 (dt, 1 H, C9-H Z), 4.32 (td, 1 H, C1-H), 
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4.25-4.19 (m, 1 H, C1-H), 3.60-3.48 (m, 1 H, C3-H), 2.22-2.0 (m, 1 H, C2-H), 1.84-1.73 
(comp, 4 H, C2-H &C-7H); 3C-NMR δ 166.3 (C5), 143.8 (C8), 136.7 (C6), 127.2 (C4), 




3-Ethylidene-4-(3-trimethylsilanylpropenyl)tetrahydropyran-2-one (2.57).  JD 2-
268.  Freshly distilled allyl trimethylsilane (0.223 mL, 160 mg, 1.41 mmol) was added to 
a solution of 2.58 (107 mg, 0.703 mmol) in degassed (sparged with Ar for >30 min) 
CH2Cl2 (3 mL) via syringe.  The solution was heated to reflux, Grubbs’s second 
generation catalyst (29 mg, 0.035 mmol) was added in one portion, and the golden brown 
solution was heated under reflux for 7 h by which time it had become dark.  The reaction 
mixture was cooled to rt, DMSO (0.121 mL, 133 mg, 1.76 mmol) was added, and the 
mixture was stirred overnight.  The mixture was concentrated under reduced pressure, 
and the residue was purified via flash chromatography eluting with EtOAc/hexanes (20-
30%) to yield 104 mg (62%) of 2.57 and 31 mg of 2.58 (28%).  1H NMR (400 MHz) δ 
7.22 (qt, J = 7.3 & 1.2 Hz, overlaps with CHCl3), 5.35 (dtd, J = 15.2 & 8.1 & 1.7 Hz, 1 
H), 5.17 (ddt, J = 15.2 & 5.4 & 1.2 Hz, 1 H), 4.33 (td, J = 11.1 & 2.7 Hz, 1 H), 4.19 (dtd, 
J = 11.1 & 3.9 & 1.3 Hz, 1 H), 3.52-3.45 (m, 1 H), 2.12-2.02 (m, 1 H), 1.78-1.68 (comp, 
4 H), 1.43 (d, J = 8 Hz, 2 H), -0.64 (s, 9 H).  13C-NMR (63 MHz) δ 166.4, 142.7, 129.1, 
128.4, 126.7, 65.0, 35.61, 29.1, 22.7, 14.1, -2.0. 
NMR assignments.  1H NMR (400 MHz) δ 7.22 (qt, overlaps with CHCl3, C6-H), 5.35 
(dtd, 1 H, C9-H), 5.17 (ddt, 1 H, C8-H), 4.33 (td, 1 H, C1-H), 4.19 (dtd, 1 H, C1-H), 
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3.52-3.45 (m, 1 H, C3-H), 2.12-2.02 (m, 1 H, C2-H), 1.78-1.68 (comp, 4 H, C2-H & C7-
H), 1.43 (d, 2 H, C10-H), -0.64 (s, 9 H, TMS).  13C-NMR (63 MHz) δ 166.4 (C5), 142.7 
(C6), 129.1 (C8 or C9), 128.4 (C4), 126.7 (C8 or C9), 65.0 (C1), 35.61 (C3), 29.1 (C2), 





methylamide (2.73). JD 2-279.  t-Butylmagnesium bromide (0.80 mL, 1.4 mmol) was 
added slowly dropwise to a vigorously stirred mixture of N,O-dimethylhydroxylamine 
hydrochloride (71 mg, 0.73 mmol) and 2.57 (108 mg, 0.453 mmol) slurried in dry THF (5 
mL) at –20 °C.  The reaction was stirred for 30 min at -20 °C, slowly warmed to rt, and 
0.5 M aqueous H2SO4 (1 mL) and EtOAc (1 mL) were added.  The layers were 
separated, and the organic layer was washed with EtOAc (3 X 1 mL).  The combined 
organic layers were washed with saturated aqueous NaHCO3 (5 mL), dried (Na2SO4), 
concentrated under reduced pressure, and the residue was purified via flash 
chromatography eluting with EtOAc/hexanes (50-75%) to yield 120 mg (78%) of 2.73 
and 10 mg of 2.57 (9%).  1H-NMR (250 MHz) δ 5.76 (q, 1 H), 5.48 (dt, J = 15.2, 7.5 Hz, 
1 H), 5.37 (dd, J = 15.2, 7.9 Hz, 1 H), 3.70-3.57 (comp, 5 H), 3.32 (q, J = 7.9 Hz, 1 H), 
3.21 (s, 3 H), 3.01 (br s, 1 H), 1.88-1.74 (comp, 5 H), 1.40 (d, J = 7.5, 2 H), -0.04 (s, 9 
H); 13C-NMR (250 MHz) 172.1, 137.1, 129.1, 128.1, 127.5, 80.8, 60.5, 40.1, 37.2, 34.7, 
22.7, 13.7, -2.0; MS CI+ m/z 300.199374 [C15H30NO3Si (M+1) requires 300.199498] 
239, 270, 284, 300 (base). 
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NMR assignments. 1H-NMR (250 MHz) δ 5.76 (q, 1 H, C10-H), 5.48 (dt, J = 15.2, 7.5 
Hz, 1 H, C5-H), 5.37 (dd, J = 15.2, 7.9 Hz, 1 H, C4-H), 3.70-3.57 (comp, 5 H, C8-H, 
C13-H), 3.32 (q, J = 7.9 Hz, 1 H, C3-H), 3.21 (s, 3 H, C9-H), 3.01 (br s, 1 H, -OH), 1.88-
1.74 (comp, 5 H, C11-H, C12-H), 1.40 (d, J = 7.5, 2 H, C6-H), -0.04 (s, 9 H, TMS); 13C-
NMR (250 MHz) 172.1 (C1), 137.1 (C2), 129.1 (C4, 5, or 10), 128.1 (C4, 5, or 10), 127.5 
(C4, 5, or 10), 80.8 (C8), 60.5 (C13), 40.1 (C9), 37.2 (C11), 34.7 (C3), 22.7 (C12), 13.7 





methoxymethylamide.  JD 2-274.  Triphenyl phosphine (142 mg, 0.551 mmol) was 
added in one potion to a stirred solution of 2.73 (81 mg, 0.27 mmol), carbon tetrabromide 
(170 mg, 0.541 mmol), and triethylamine (0.113 mL, 0.811 mmol) in dry CH2Cl2 (2.7 
mL).  The mixture was stirred for 10 min whereupon H2O (5 mL) was added, the layers 
were separated, and the aqueous layer was washed with CH2Cl2 (4 X 5 mL).  The 
combined organic layers were dried (Na2SO4), concentrated under reduced pressure, and 
the residue was purified via flash chromatography eluting with EtOAc/hexanes (20%) to 
yield 83 mg (85%) of the bromide.  1H-NMR (250 MHz) δ 5.69 (q, J = 7.0 Hz, 1 H), 5.53 
(dt, J = 15.2, 7.8 Hz, 1 H), 5.18 (dd, J = 15.2, 9.0 Hz, 1 H), 3.86 (s, 3 H), 3.65-3.30 
(comp, 3 H), 3.15 (s, 3 H), 2.18-1.98 (m, 2 H), 1.75 (d, J = 7.0 Hz, 3 H), 1.40 (d, J = 7.8, 
2 H), -0.05 (s, 9 H); 13C-NMR (250 MHz) δ 170.9, 137.4, 129.3, 127.3, 127.1, 60.7, 
41.1, 36.6, 34.4, 32.8, 22.8, 13.2, -2.0. 
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NMR assignments.  1H-NMR (250 MHz) δ 5.69 (q, J = 7.0 Hz, 1 H, C10-H), 5.53 (dt, J 
= 15.2, 7.8 Hz, 1 H, C5-H), 5.18 (dd, J = 15.2, 9.0 Hz, 1 H, C4-H), 3.86 (s, 3 H, C8-H), 
3.65-3.30 (comp, 3 H, C13-H, C3-H), 3.15 (s, 3 H, C9-H), 2.18-1.98 (m, 2 H, C12-H), 
1.75 (d, J = 7.0 Hz, 3 H, C11-H), 1.40 (d, J = 7.8, 2 H, C6-H), -0.05 (s, 9 H, C7-H); 13C-
NMR (250 MHz) δ 170.9 (C1), 137.4, 129.3 (C4, 5, or 10), 127.3 (C4, 5, or 10), 127.1 
(C4, 5, or 10), 60.7 (C8), 41.1 (C9), 36.6 (C11), 34.4 (C3), 32.8 (C13), 22.8 (C12), 13.2 




3-(2-Bromoethyl)-2-ethylidene-6-trimethylsilanylhex-4-enal (2.56). JD 2-282.  
Diisobutylaluminum hydride (0.44 mL, 1 M in hexanes, 0.44 mmol) was added dropwise 
to a solution of the bromide from the previous step (97 mg, 0.27 mmol) in toluene (2.7 
mL) at –78 °C.  The mixture was stirred for 20 min, whereupon MeOH (0.22 mL, 5.4 
mmol) was added.  The mixture was stirred for 5 min, warmed to rt, and saturated 
aqueous Rochelle’s salt (5 mL) was added.  The heterogeneous mixture was stirred 
vigorously for 30 min, the layers were separated, and the aqueous layer was washed with 
EtOAc (2 X 5 mL).  The combined organic layers were dried (Na2SO4), concentrated 
under reduced pressure, and the residue was purified via flash chromatography eluting 
with EtOAc/hexanes (20%) to yield 90 mg (quant.) of 2.56.  1H-NMR (500 MHz) δ 9.30 
(d, J = 1.6 Hz, 1 H), 6.56 (q, J = 7.1 Hz, 1 H), 5.50-5.40 (comp, 2 H), 3.49 (qd, J = 7.4, 
1.6 Hz, 1 H), 3.35 (ddd, J = 9.5, 7.1, 5.5 Hz, 1 H), 3.28 (ddd, J = 9.6, 6.6, 5.6 Hz, 1 H), 
2.27-2.2 (m, 1 H), 2.14-2.07 (m, 1 H), 2.03 (d, J = 7.1 Hz, 3 H), 1.42-1.35 (m, 2 H), -0.06 
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(s, 9 H); 13C-NMR (500 MHz) δ 194.8, 151.2, 145.4, 128.7, 127.2, 39.1, 35.1, 32.7, 22.7, 
15.0, –2.0; MS CI+ m/z 303.077213 [C13H24OSiBr (M+1) requires 303.07798] 223, 303 
(base), 305. 
NMR assignments.  1H-NMR (500 MHz) δ 9.30 (d, J = 1.6 Hz, 1 H, C1-H), 6.56 (q, J = 
7.1 Hz, 1 H, C8-H), 5.50-5.40 (comp, 2 H, C4-H, C5-H), 3.49 (qd, J = 7.4, 1.6 Hz, 1 H, 
C3-H), 3.35 (ddd, J = 9.5, 7.1, 5.5 Hz, 1 H, C11a-H), 3.28 (ddd, J = 9.6, 6.6, 5.6 Hz, 1 H, 
C11b-H), 2.27-2.2 (m, 1 H, C10a-H), 2.14-2.07 (m, 1 H, C10b-H), 2.03 (d, J = 7.1 Hz, 3 
H, C9-H), 1.42-1.35 (m, 2 H, C6-H), -0.06 (s, 9 H, C7-H); 13C-NMR (500 MHz) δ 194.8 
(C1), 151.2 (C8), 145.4 (C2), 128.7 (C4 or C5), 127.2 (C4 or C5), 39.1 (C3), 35.1 (C10), 
32.7 (C11), 22.7 (C6), 15.0 (C9), –2.0 (C7). 
 
 




















4-Bromo-1-tosyl-N-(tert-butoxycarbonyl)tryptophan methyl ester (R-4.37).  JD 3-
220.  In a round bottom flask fitted with a rubber septum 4-bromo-1-tosyl-N-(tert-
butoxycarbonyl)dehydrotryptophan methyl ester (4.8, 3.00 g, 5.46 mmol)134 was dried via 
alternating evacuation/N2 purge.  Dry MeOH (150 mL) which had been sparged with a 
stream of Ar while being sonicated was added via syringe, and the mixture was heated to 
dissolve 4.8.  The solution was cooled, and [Rh(cod)S,S-DIPAMP]BF4 (120 mg, 0.158 
mmol), which was synthesized by the method of Knowles,148 in dry MeOH was added via 
syringe.  The flask was placed in a high pressure stainless steel bomb, the septum was 
removed, the bomb was evacuated and backfilled with Ar.  The bomb was then evacuated 
again and backfilled with H2 (5 cycles, 100 psi).  The reaction mixture was then stirred 5 
d.  The reaction progress was checked periodically via no D 1H-NMR; TLC is not viable 
due to the similar Rf values of the starting material and the product.150  The mixture was 
concentrated under reduced pressure, the residue was dissolved in EtOAc, and the 
mixture was filtered through a pad of silica washing with EtOAc.  The combined filtrate 
and washings were concentrated under reduced pressure, and the residue was purified via 
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flash chromatography eluting with EtOAc/hexanes (30%) to yield 2.90 g (96%) of R-
4.37.  1H-NMR spectral characteristics matched those for S- 4.37.134  HPLC: Chiracel-OD 
column eluting with 98:2 hexanes/isopropanol at 1 mL/min, tR = 30.04 min (R), tR = 





























tert-Butyl (R)-1-(4-bromo-1-tosyl-1H-indol-3-yl)but-3-yn-2-ylcarbamate (4.40).  JD 
4-250.  A solution of R-4.37 (1 g, 1.82 mmol) in dry toluene (20 mL) was cooled to -78 
°C, and DIBAL (5.44 mL, 1 M in hexanes, 5.44 mmol) was added dropwise via syringe 
with vigorous stirring.  The mixture was stirred for 1 h, whereupon the excess DIBAL 
was destroyed via dropwise addition of dry MeOH (20 mL).  The cooling bath was 
removed and the mixture was warmed to rt.  Ohira’s reagent (4.14, 1.05 g, 5.44 mmol) 
and K2CO3 (752 mg, 5.55 mmol) were added sequentially in one portion each.  The 
mixture was stirred overnight whereupon saturated aqueous Rochelle’s salt and EtOAc 
were added.  The mixture was stirred vigorously for 15 min, and the layers were 
separated.  The aqueous layer was washed with EtOAc, the combined organic layers were 
dried (Na2SO4), and concentrated under reduced pressure.  The residue was purified via 
flash chromatography eluting with EtOAc/hexanes (30%) to yield 616 mg (70%) of 4.40.  
HPLC (JD 4-202): Chiracel-OD column eluting with 98:2 hexanes/isopropanol at 1 
mL/min, tR = 18.74 min (R), tR = 28.38 min (S), er = 8.5:1.  1H-NMR (250 MHz) δ 7.91 
(d, J = 8.2 Hz, 1 H), 7.71 (d, J = 8.2 Hz, 2 H), 7.54 (s, 1 H), 7.35 (d, J = 8.2 Hz, 1 H), 
7.20 (d, J = 8.2 Hz, 2 H), 7.09 (t, J = 8.2 Hz, 1 H), 4.80 (comp, 2 H), 3.37 (m, 2 H), 2.32 
(s, 3 H), 2.27 (s, 1 H), 1.34 (br s, 9 H); 13C-NMR (63 MHz) δ 154.5, 145.2, 136.2, 134.8, 
129.9, 128.7, 127.9, 126.9, 126.6, 125.4, 117.8, 114.4, 112.8, 83.0, 80.1, 71.8, 43.5, 32.5, 
28.2, 21.6; MS CI+ m/z 516.071374 [C24H25BrN2O4S (M+) requires 516.071840] 417, 
419, 461 (base), 463. 
NMR Assignments. 1H-NMR (250 MHz) δ 7.91 (d, J = 8.2 Hz, 1 H, C10-H or C12-H), 
7.71 (d, J = 8.2 Hz, 2H, C4-H), 7.54 (s, 1 H, C6-H), 7.35 (d, J = 8.2 Hz, 1 H, C10-H or 
C12-H), 7.20 (d, J = 8.2 Hz, 2 H, C3-H), 7.09 (t, J = 8.2 Hz, 1 H, C11-H), 4.80 (comp, 2 
H, C15-H, NH), 3.37 (m, 2 H, C14-H), 2.32 (s, 3 H, C1-H), 2.27 (s, 1 H, C17-H), 1.34 (br 
s, 9 H, C20-H); 13C-NMR (63 MHz) δ 154.5 (C18), 145.2 C(13), 136.2 (C2), 134.8 (C8), 
129.9 (C5), 128.7 (C3), 127.9 (C4), 126.9 (C10), 126.6 (C11), 125.4 (C6), 117.8 (C12), 
114.4 (C9), 112.8 (C7), 83.0 (C16), 80.1 (C19), 71.8 (C17), 43.5 (C15), 32.5 (C14), 28.2 































4.12).  (JD 4-253).  A stock solution of NaHMDS (1.2 mL, 1.17 M, 1.4 mmol) was added 
dropwise to a solution of 4.40 (616 mg, 1.19 mmol) in dry THF (2 mL) cooled to -78 °C.  
The mixture was stirred for 1h 15 min and then freshly distilled dimethyl sulfate (0.17 
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mL, 1.8 mmol) was added dropwise.  The mixture was stirred 10 min and the cooling 
bath was removed.  The reaction vessel warmed to rt over 10-20 min, and after 20 
additional min saturated aqueous NH4Cl was added.  The layers were separated.  The 
aqueous layer was washed with EtOAc, the combined organic layers were dried 
(Na2SO4), and concentrated under reduced pressure.  The residue was purified via flash 
chromatography eluting with EtOAc/hexanes (10-30%) to yield 601 mg (95%) of R-4.12.  
1H-NMR spectral characteristics matched those for racemic 4.12.194  1H NMR (500 MHz, 
DMSO-d6, 90 °C) δ 7.92 (dd, J = 8.1, 0.7 Hz, 1 H), 7.77 (dt, J = 8.4, 1.2 Hz, 2 H), 7.68 
(s, 1 H), 7.45 (dd, J = 8.1, 0.7 Hz, 1 H), 7.37 (dd, J = 8.4, 1.2 Hz, 2 H), 7.22 (t, J = 8.1 
Hz, 1 H), 5.34 (ddd, J = 9.9, 5.2, 2.4 Hz, 1 H), 3.37 (ddd, J = 14.5, 5.2, 1.0 Hz, 1 H), 3.20 
(d, J = 2.4 Hz, 1 H), 3.17 (dd, J = 14.5, 9.9 Hz, 1 H), 2.84 (s, 3 H), 2.33 (s, 3 H), 1.04 (s, 
9 H); 13C NMR (125 MHz, DMSO-d6, 90 °C) δ 153.4, 145.0, 135.5, 133.8, 129.7, 127.6, 
127.2, 126.7, 126.1, 125.2, 116.9, 113.2, 112.2, 81.0, 78.6, 74.7, 47.7, 29.1, 28.3, 27.0, 
20.4; IR (CHCl3) 3306, 3014, 2980, 2632, 1915, 1685, 1598, 1556, 1369 cm-1; MS CI+ 
m/z 530.0873 [C25H27N2O4SBr (M+1) requires 530.0875], 517, 505, 475, 431 (base), 402, 
364, 321, 275, 187. 
NMR Assignments.  1H NMR (500 MHz, DMSO-d6, 90 °C) δ 7.92 (dd, J = 8.1, 0.7 Hz, 
1 H, C12-H), 7.77 (dt, J = 8.4, 1.2 Hz, 1 H, C4-H), 7.68 (s, 1 H, C6-H), 7.45 (dd, J = 8.1, 
0.7 Hz, 1H, C10-H), 7.37 (dd, J = 8.4, 1.2 Hz, 2 H, C3-H), 7.22 (t, J = 8.1 Hz, 1 H, C11-
H), 5.34 (ddd, J = 9.9, 5.2, 2.4 Hz, 1 H, C15-H), 3.37 (ddd, J = 14.5, 5.2, 1.0 Hz, 1 H, 
C14-H), 3.20 (d, J = 2.4 Hz, 1 H, C17-H), 3.17 (dd, J = 14.5, 9.9 Hz, 1 H, C14-H), 2.84 
(s, 3 H, C18-H), 2.33 (s, 3 H, C1-H), 1.04 (s, 9 H, C21-H); 13C NMR (125 MHz, DMSO-
d6, 90 °C) δ 153.4 (C19), 145.0 (C13), 135.5 (C2), 133.8 (C8), 129.7 (C5), 127.6 (C3), 
127.2 (C4), 126.7 (C10), 126.1 (C11), 125.2 (C6), 116.9 (C12), 113.2 (C9), 112.2 (C7), 
























(R)-N-Methyl-6-methylene-2-tosyl-2,6,7,8-tetrahydrobenzo[cd]indol-7-amine (4.46).  
JD 5-118, 5-119.  Dry, degassed (sparged with Ar under sonication for >30 min) CH3CN 
(94 mL) was added via syringe to a mixture of the alkyne R-4.12 (500 mg, 0.941 mmol), 
Pd(PPh3)4 (163 mg, 0.141 mmol), and Bu4NCl (392 mg, 1.41 mmol) under Ar, and 
1,2,2,6,6-pentamethylpiperidine (510 μL, 2.82 mmol) was then added via syringe.  The 
mixture was heated to 80 °C, and HCO2H (71 μL, 1.9 mmol) was added via syringe.  The 
reaction was stirred for 2 h at 80 °C, and then cooled to rt.  The solvent was removed 
under reduced pressure, and the residue was partially purified via flash chromatography 
eluting with EtOAc/hexanes (15-50%).  The solvent was concentrated under reduced 
pressure, the residue was dissolved in MeOH (8.5 mL), p-TsOH·H2O (328 mg, 1.73 
mmol) was added in one portion, and the reaction was warmed to 35 °C.  The mixture 
was stirred overnight, cooled to rt, and saturated aqueous NaHCO3 (25 mL) and CH2Cl2 
(25 mL) were added.  The layers were separated, the aqueous layer was washed with 
CH2Cl2 (3 X 25 mL), the combined organic layers were dried (Na2SO4), the solvent was 
removed under reduced pressure, and the residue was purified via flash chromatography 
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eluting with EtOH/CH2Cl2 (5-10%) to yield 148 mg (44%) of 4.46.  1H NMR (300 MHz) 
δ 7.81-7.75 (comp, 3 H), 7.37-7.20 (comp, 5 H), 5.70 (s, 1 H), 5.22 (s, 1 H), 3.57 (app t, J 
= 4.0 Hz, 1 H), 3.09-2.95 (comp, 2 H), 2.34 (s, 3 H), 2.30 (s, 3 H); 13C NMR (75 MHz) δ 
145.0, 141.9, 136.1, 134.0, 130.2, 129.0 (2), 127.2, 126.3, 121.5, 118.1, 117.5, 113.4, 
112.3, 61.7, 34.2, 29.2, 21.9; IR (neat) cm-1 3334, 2925, 1360, 1175; MS (FAB) m/z 
353.1324 [C20H21N2O2S (M+1) requires 353.7324], 353(base). 
NMR Assignments.  1H NMR (300 MHz) δ 7.81-7.75 (comp, 3 H, C16-H & C10-H), 
7.37-7.20 (comp, 5 H, C17-H & C9-H & C8-H & C2-H), 5.70 (s, 1 H, C13-H), 5.22 (s, 1 
H, C13-H), 3.57 (app t, J = 4.0 Hz, 1 H, C5-H), 3.09-2.95 (comp, 2 H, C4-H), 2.34 (s, 3 
H, C14-H), 2.30 (s, 3 H, C19-H); 13C NMR (75 MHz) δ 145.0 (C11), 141.9 (C2), 136.1 
(C18), 134.0 (C5), 130.2 (3), 129.0 (C4, C14), 127.2 (C13), 126.3 (C16), 121.5 (C6), 
118.1 (C12 or C17), 117.5 (C12 or C17), 113.4 (C15), 112.3 (C7), 61.7 (C9), 34.2 (C10), 





enyl)benzo[cd]indol-7-amine (4.27).  JD 5-52.  Paraformaldehyde (6 mg, 0.2 mmol) 
was added to a solution of 4.46 (25 mg, 0.071 mmol) in MeOH (1 mL) in one portion, 
 150
 151
and the mixture was stirred overnight.  The solvent was remove under reduced pressure, 
the residue was dissolved in THF (1 mL).  Bispentadienyl zinc was made by adding a 
solution of n-BuLi (284 μL, 2.5 M, 0.709 mmol) to a solution of 1,4-pentadiene (73 μL, 
0.71 mmol) in THF (0.4 mL) cooled to 0 °C.  After 15 min a stock solution of ZnBr2 (355 
μL, 1 M, 0.355 mmol) was added, and the solution was warmed to rt and stirred for 15 
min.  The solution of pentadienyl zinc thus made was added to the solution of the N,O-
acetal 4.68 cooled to -78 °C.  The mixture was stirred and warmed to rt overnight 
whereupon H2O (2 mL)) was added, and saturated aqueous NH4Cl was added until all 
formed solids dissolved.  CH2Cl2 (5 mL) was added, the layers were separated, and the 
aqueous layer was washed with CH2Cl2 (3 X 5 mL).  The combined organic layers were 
dried (Na2SO4), concentrated under reduced pressure, and the residue was purified via 
flash chromatography eluting with EtOAc/hexanes (10-100%) then EtOH/EtOAc (0-
100%) to yield 18 mg (61%) of 4.27, 9 mg (30%) of 4.69, and a trace of 4.46.  1H-NMR 
(400 MHz) δ 7.76-7.70 (comp, 3 H), 7.32 (d, J = 7.6 Hz, 1 H), 7.26 (t, J = 7.5 Hz, 1 H), 
7.19-7.14 (comp, 3 H), 5.75 (s, 1 H), 5.69-5.54 (comp, 2 H), 5.40 (s, 1 H), 4.96-4.89 
(comp, 4 H), 3.57 (t, J = 6.2 Hz, 1 H), 2.96-2.91 (comp, 2 H), 2.85 (m, 1 H), 2.50 (d, J = 
7.6 Hz, 2 H), 2.31 (s, 3 H), 2.21 (s, 3 H); 13C-NMR (100 MHz) 144.6, 141.0, 139.5, 
135.5, 133.6, 130.4, 129.8, 129.1, 126.7, 125.7, 119.7, 119.1, 117.0, 114.9, 114.8, 112.6, 
112.3, 64.4, 59.1, 46.4, 38.2, 23.1, 21.5; MS CI+ m/z 433.195247 [C26H29N2O2S (M+1) 
requires 433.194975] 365, 433 (base). 
NMR Assignments.  1H-NMR (400 MHz) δ 7.76-7.70 (comp, 3 H, C4-H, C15-H), 7.32 
(d, J = 7.6 Hz, 1 H, C13-H), 7.26 (t, J = 7.5 Hz, 1 H, C14-H), 7.19-7.14 (comp, 3 H, C3-
H, C6-H), 5.75 (s, 1 H, C17a-H), 5.69-5.54 (comp, 2 H, C20-H), 5.40 (s, 1 H, C17b-H), 
4.96-4.89 (comp, 4 H, C21-H), 3.57 (t, J = 6.2 Hz, 1 H, C9-H), 2.96-2.91 (comp, 2 H, 
C8-H), 2.85 (m, 1 H, C19-H), 2.50 (d, J = 7.6 Hz, 2 H, C18-H), 2.31 (s, 3 H, C1-H), 2.21 





(4.89).  JD 5-69.  A solution of (S)-Schrock-Hoveyda catalyst (S-4.23, 22 mg, 0.029 
mmol) in dry benzene (0.75 mL) was added via syringe to a solution of 4.27 (25 mg, 
0.058 mmol) in dry benzene (5 mL) in a CEM 8 mL reactor equipped with a stir bar and 
septum.  The vessel was irradiated with microwaves (50 W) while being externally 
cooled with compressed air for 30 min.  The crude reaction mixture was concentrated 
under reduced pressure and the residue was purified via flash chromatography eluting 
with EtOAc/hexanes (20-75%) to yield 13 mg (54%) of 4.89.  1H NMR (500 MHz, C6D6) 
δ 8.07 (dd, J = 7.8, 1 Hz, 1 H), 7.72-7.70 (comp, 2 H), 7.13-7.10 (comp, 3 H), 6.51-6.49 
(m, 2 H), 6.20 (app d, J = 3.7 Hz, 1 H), 6.06 (ddd, J = 17.4, 10.0, 7.6 Hz, 1 H), 5.05-4.99 
(comp, 2 H), 2.99 (dd, J = 15.1, 5.3 Hz, 1 H), 2.73-2.63 (comp, 2 H), 2.53 (ddd, J = 11.3, 
2.6, 0.8 Hz, 1 H), 2.40 (dd, J = 11.3, 4.0 Hz, 1 H), 2.34 (ddd, J = 15.1, 11.6, 2.2 Hz, 1 H), 
2.12 (s, 3 H), 1.63 (s, 3 H); MS CI+ m/z 405.1637 [C24H25N2O2S (M+1) requires 
405.1637] (base), 121, 251, 300. 
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NMR assignments.  1H NMR (500 MHz, C6D6) δ 8.07 (dd, J = 7.8, 1 Hz, 1 H, C18-H), 
7.72-7.70 (comp, 2 H, C4-H), 7.13-7.10 (comp, 3 H, C6-H, C16-H, C17-H), 6.51-6.49 
(m, 2 H, C3-H), 6.20 (app d, J = 3.7 Hz, 1 H, C13-H), 6.06 (ddd, J = 17.4, 10.0, 7.6 Hz, 1 
H, C21-H), 5.05-4.99 (comp, 2 H, C22-H), 2.99 (dd, J = 15.1, 5.3 Hz, 1 H, C8α-H), 2.73-
2.63 (comp, 2 H, C9-H, C12-H), 2.53 (ddd, J = 11.3, 2.6, 0.8 Hz, 1 H, C11α-H), 2.40 
(dd, J = 11.3, 4.0 Hz, 1 H, C11β-H), 2.34 (ddd, J = 15.1, 11.6, 2.2 Hz, 1 H, C8β-H), 2.12 





yl)ethane-1,2-diol (4.90).  JD 4-135.  This representative example was performed on 
racemic 4.89.  A solution of osmium tetroxide (6 mg, 0.03 mmol) in THF (0.1 mL) was 
added to a stirred solution of 4.89 and N,N,N’,N’-tetramethylethylenediamine (TMEDA, 
5 μL, 0.03 mmol) in THF (0.4 mL) cooled to -78 °C.  The orange/brown mixture was 
stirred and allowed to warm to room temperature overnight in the dark, whereupon 
saturated aqueous sodium bisulfite was added.  The mixture was heated to 70 °C for 3.5 
h, cooled to room temperature, diluted with CH2Cl2 (2 mL), and filtered through a cotton 
pad.  The layers were separated, and the aqueous layer was washed with CH2Cl2 (5 X 2 
 153
 154
mL).  The combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure, and the residue was purified via flash chromatography eluting with 
EtOH/EtOAc (20-100%) to yield 8 mg (72%) 4.90 as a 6.5:1 ratio of diastereomers.  1H 
NMR major diastereomer (500 MHz, C6D6) δ 8.07 (dd, J = 8.0, 0.6 Hz, 1 H), 7.74-7.70 
(m, 2 H), 7.12-7.08 (comp, 3H), 6.54-6.50 (m, 2 H), 6.27 (d, J = 5.6 Hz, 1 H), 3.77 (td, J 
= 6.3, 3.0 Hz, 1 H), 3.50 (d, J = 6.3 Hz, 2 H), 2.84 (dd, J = 15.1, 5.2 Hz, 1 H), 2.68 (d, J = 
11.6 Hz, 1 H), 2.46 (ddt, J = 11.6, 5.2, 2.4 Hz, 1 H), 2.20 (ddd, J = 15.1, 11.6, 2.1 Hz, 1 
H), 2.17-2.13 (m, 1 H), 2.11 (dd, J = 11.6, 4.3, 1 H), 1.89 (s, 3 H), 1.64 (s, 3 H); 13C-
NMR (125 MHz) 144.4, 136.5, 135.1, 134.2, 129.8, 129.6, 129.0, 128.5, 126.9, 126.2, 
123.2, 120.4, 117.7, 116.9, 112.9, 74.5, 65.1, 61.9, 54.3, 42.8, 38.9, 27.1, 21.0 
NMR assignments.  1H NMR (500 MHz, C6D6) δ 8.07 (dd, J = 8.0, 0.6 Hz, 1 H, C18-
H), 7.74-7.70 (m, 2 H, C4-H), 7.12-7.08 (comp, 3H, C6-H, C16-H, C17-H), 6.54-6.50 
(m, 2 H, C3-H), 6.27 (d, J = 5.6 Hz, 1 H, C13-H), 3.77 (td, J = 6.3, 3.0 Hz, 1 H, C21-H), 
3.50 (d, J = 6.3 Hz, 2 H, C22-H), 2.84 (dd, J = 15.1, 5.2 Hz, 1 H, C8-H), 2.68 (d, J = 11.6 
Hz, 1 H, C11-H), 2.46 (ddt, J = 11.6, 5.2, 2.4 Hz, 1 H, C9-H), 2.20 (ddd, J = 15.1, 11.6, 
2.1 Hz, 1 H, C8-H), 2.17-2.13 (m, 1 H, C12-H), 2.11 (dd, J = 11.6, 4.3, 1 H, C11-H), 
1.89 (s, 3 H, C10-H), 1.64 (s, 3 H, C1-H); 13C-NMR partial assignment (125 MHz) 144.4 
(C5), 136.5 (C2), 135.1, 134.2 (C19), 129.8 (C3), 129.6, 129.0, 128.5, 126.9 (C4), 126.2 
(C16 or C17), 123.2 (C13), 120.4 (C20), 117.7 (C6), 116.9, 112.9 (C18), 74.5 (C21), 65.1 






yl)methanol (N-tosyl isolysergol, 4.123).  JD 6-232.  To two stirred solutions of 4.90 (4 
mg, 0.009 mmol each) in MeOH (0.2 mL each) was added H5IO6 (6 mg, 0.03 mmol 
each).  The mixtures were stirred for 45 min, one was cooled to 0 °C, one was cooled to -
20 °C, TFA (0.1 mL each) was added dropwise, and NaCNBH3 (57 mg, 0.91 mmol each) 
was added portionwise.  The reactions momentarily darkened, then lightened, and gas 
was evolved while the reaction mixtures were allowed to stir and warm to rt.  The 
reaction mixtures, were made basic (pH > 10) with aqueous NaOH (3 M, ca 2 mL each), 
CH2Cl2 (2 mL each) was added, H2O (2 mL each) was added, the layers were separated, 
and the aqueous layer was washed with CH2Cl2 (4 X 2 mL each).  The combined organic 
layers were dried (Na2SO4), concentrated under reduced pressure, and the residue from 
each reaction was analyzed via 1H-NMR.  The samples were very similar, so they were 
combined and purified via flash chromatography eluting with MeOH/CHCl3 (5-10%) to 
yield 4 mg (54%) of 4.123.  1H NMR (500 MHz, CD3OD) δ 7.74 (d, J = 4.4 Hz, 1 H), 
7.69 (d, J = 8.5 Hz, 2 H), 7.27 (comp, 2 H), 7.21-7.14 (comp, 3 H), 6.43 (d, J = 6.07 Hz, 
1 H), 3.97 (dd, J = 10.3, 3.0, 1 H), 3.77 (dt, J = 10.3, 2.4 Hz, 1 H), 3.42 (dd, J = 15.2, 5.6 
Hz, 1 H), 3.03-2.96 (comp, 2 H), 2.79 (ddd, J = 11.3, 3.7, 2.1 Hz, 1 H), 2.53-2.45 (comp, 
4 H), 2.41 (br s, 1 H), 2.31 (s, 3 H); 13C-NMR (125 MHz) δ 144.7, 135.4, 135.3, 133.6, 
129.8, 129.1, 128.6, 126.6, 125.9, 123.2, 120.0, 117.7, 116.5, 112.5, 66.6, 62.1, 58.1, 
43.5, 36.5, 27.2, 21.5; IR (PhH) 3378, 2993, 2852, 1724, 1666, 1597 cm-1; MS CI+ m/z 




(isolysergol, 4.122).  JD 6-238.  Magnesium turnings (ca 10 mg) were added to a 
vigorously stirred solution of 4.123 (4 mg, 0.01) in MeOH (0.5 mL).  The reaction was 
stirred 5 h, filtered through a pad of celite, and the filtrate washed with CHCl3.  The 
mixture was concentrated and the residue was filtered through a pad of silica washing 
with MeOH/CHCl3 (50%).  The mixture was concentrated under reduced pressure and 
the residue was purified via flash chromatography eluting with MeOH/CHCl3 (10-30%) 
to yield 2 mg of 4.122 (72%).  1H NMR (500 MHz, CD3OD/CDCl3, 1:1) δ 7.17 (dd, J = 
5.1, 3.7 Hz, 1 H), 7.09-7.06 (comp, 2 H), 6.89 (d, J = 1.6 Hz, 1 H), 6.40 (app d, J = 4.7, 1 
H), 3.82 (dd, J = 10.3, 4.2 Hz, 1 H), 3.71 (ddd, J = 10.3, 5.5, 0.7 Hz, 1 H), 3.48 (dd, J = 
14.4, 5.5 Hz, 1 H), 3.17 (ddt, J = 11.5, 5.5, 2.2 Hz, 1 H), 2.98 (dd, J = 11.4, 1.8 Hz, 1 H), 
2.77 (dd, J = 11.4, 3.8 Hz, 1 H), 2.63 (ddd, J = 14.4, 11.5, 1.6 Hz, 1 H), 2.53 (s, 3 H), 2.5-
2.45 (m, 1 H); 13C-NMR (125 MHz) δ 137.5, 134.8, 128.7, 126.8, 123.3, 121.2, 119.3, 
111.9, 110.3, 110.2, 65.9, 63.8, 56.4, 43.7, 37.6, 27.8. 
NMR assignments.  1H NMR (500 MHz) δ 7.17 (dd, J = 5.1, 3.7 Hz, 1 H, C13-H), 7.09-
7.06 (comp, 2 H, C11-H, C12-H), 6.89 (d, J = 1.6 Hz, 1 H, C1-H), 6.40 (app d, J = 4.7, 1 
H, C8-H), 3.82 (dd, J = 10.3, 4.2 Hz, 1 H, C16-H), 3.71 (ddd, J = 10.3, 5.5, 0.7 Hz, 1 H, 
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C16-H), 3.48 (dd, J = 14.4, 5.5 Hz, 1 H, C3α-H), 3.17 (ddt, J = 11.5, 5.5, 2.2 Hz, 1 H, 
C4-H), 2.98 (dd, J = 11.4, 1.8 Hz, 1 H, C6α-H), 2.77 (dd, J = 11.4, 3.8 Hz, 1 H, C6β-H), 
2.63 (ddd, J = 14.4, 11.5, 1.6 Hz, 1 H, C3α-H), 2.53 (s, 3 H, C5-H), 2.5-2.45 (m, 1 H, 
C7-H); 13C-NMR (125 MHz) δ 137.5, 134.8, 128.7, 126.8, 123.3, 121.2, 119.3, 111.9, 




hexahydroindolo[4,3-fg]quinoline (4.130).  Method 1:  JD-6-234.  N-Ts-isolysergol 
(4.123, ca 3mg, 0.00734 mmol) from a diol cleavage reaction was used without 
purification.  Imidazole (5 mg, 0.0734 mmol) and tert-butyldimethylsilyl chloride (11 
mg, 0.0734 mmol) were added to the solution of 4.123 in CH2Cl2 (0.25 mL).  The 
reaction progress was monitored by TLC, and when 4.123 had been consumed H2O (2 
mL) was added, the layers were separated, and the aqueous layer was washed with 
CH2Cl2 (4 X 2 mL).  The combined organic layers were dried (Na2SO4), concentrated 
under reduced pressure, and purified via flash chromatography eluting with 
EtOAc/hexanes (20-100%) to yield 1 mg (26%) of 4.130. 
Method 2:  JD 6-144, 6-181, 6-187, 6-189.  Imidazole (31 mg, 0.456 mmol) and tert-
butyldimethylsilyl chloride (34 mg, 0.228 mmol) were added to a solution of 4.90 (20 
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mg, 0.0456 mmol) in CH2Cl2 (0.5 mL).  The reaction was stirred overnight whereupon 
H2O (2 mL) was added, the layers were separated, and the aqueous layer was washed 
with CH2Cl2 (4 X 2 mL).  The combined organic layers were dried (Na2SO4), 
concentrated under reduced pressure, and purified via flash chromatography eluting with 
EtOAc/hexanes (20-100%) the EtOH/EtOAc (0-100%) to yield 18 mg (59%) of 4.132.  
Solid NH4F (3 mg, 0.0810) was added in one portion to a solution of 4.132 (12 mg, 
0.0178 mmol) in MeOH (1 mL) in a plastic vessel (Eppendorf type tube) and stirred for 6 
h whereupon saturated aqueous NaHCO3 (2 mL) and CH2Cl2 (2 mL) were added.  The 
layers were separated and the aqueous layer was washed with CH2Cl2 (4 X 2 mL), the 
combined organic layers were dried (Na2SO4), the solvent was removed under reduced 
pressure, and the residue was purified via flash chromatography to yield 5 mg (50%) of 
4.133.  DMSO (26 μL, 0.362 mmol) was added dropwise to a stirred solution of oxalyl 
chloride (16 μL, 0.180 mmol) in CH2Cl2 (0.25 mL) cooled to -78 °C.  After 15 min, 
4.133 (5 mg, 0.00904 mmol) dissolved in CH2Cl2 (0.5, 2 X 0.25 mL) was added 
dropwise, the mixture was stirred 15 min, and NEt3 (80 μL, 0.271 mmol) was added 
dropwise.  The mixture was stirred and allowed to warm to rt over ca 45 min whereupon 
several drops of EtOH was added, and the reaction mixture was filtered through a pad of 
silica washing with EtOAc.  The mixture was concentrated under reduced pressure, the 
residue was dissolved in EtOAc, the mixture was filtered through a pad of silica washing 
with EtOAc, and the mixture was concentrated under reduced pressure to yield 5 mg 
(quant.) of 4.131, which was used directly in the next step.  A solution of 4.131 in PhMe 
(1 mL) was degassed (freeze, pump, thaw 3 cycles), Wilkinson’s catalyst 
(tris(triphenylphosphine)rhodium(I) chloride, 17 mg, 0.0181 mmol) was added, the 
mixture was degassed (freeze, pump, thaw 3 cycles), and the mixture was heated to 120 
°C for 30 min.  The mixture was concentrated under reduced pressure, and the residue 
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was purified via flash chromatography eluting with EtOAc/hexanes (20-100%) to yield 1 
mg (21%) of 4.130.  1H NMR (400 MHz) δ 7.76-7.68 (comp, 3 H), 7.28-7.14 (comp, 
4H), 6.34 (app d, J = 3.2 Hz, 1 H), 3.72-3.58 (comp, 2 H), 3.36 (dd, J = 15.4, 5.4 Hz, 1 
H), 3.02-2.94 (mult, 1 H), 2.89 (d, J = 12.0 Hz, 1 H), 2.52-2.38 (comp, 6 H), 2.32 (s, 3 
H), 0.88 (s, 9 H), 0.03 (s, 6 H). 
NMR assignments.  1H NMR (400 MHz) δ 7.76-7.68 (comp, 3 H, C4-H, C18-H), 7.28-
7.14 (comp, 4H, C3-H, C6-H, C16-H, C17-H), 6.34 (app d, J = 3.2 Hz, 1 H, C13-H), 
3.72-3.58 (comp, 2 H, C21-H), 3.36 (dd, J = 15.4, 5.4 Hz, 1 H, C8-H), 3.02-2.94 (mult, 1 
H, C9-H), 2.89 (d, J = 12.0 Hz, 1 H, C11-H), 2.52-2.38 (comp, 6 H, C8-H, C10-H, C11-
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